This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Medical observation and evaluation for suspected diseases and conditions
Z21_MEDICAL_OBSER_EVALU_SUSPECTED_DISEA_CONDI
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
90952 |
4. Check minimum number of eventsNone |
90952 |
5. Include endpointsNone |
90952 |
6. Filter based on genotype QC (FinnGen only) |
90952 |
Control definitions (FinnGen only)
- Control exclude
- Z21_PERSONS_ENCOUNTERI_HEALTH_SERVI_EXAM_INVES
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z[0-1]
Similar endpoints
↥List of similar endpoints to
Medical observation and evaluation for suspected diseases and conditions
based on the number of shared cases.
Similar with more cases:
- Persons encountering health services for examination and investigation
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 90952 | 53510 | 37442 |
| Unadjusted period prevalence (%) | 17.53 | 18.24 | 16.51 |
| Median age at first event (years) | 54.32 | 50.76 | 59.41 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2713
- Matched controls
- 19119
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
50.9
323.0
582
102
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
245.7
323.0
413
14
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
121.7
323.0
1137
113
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
810.6
323.0
394
*
Z01.8
ICD-10 Finland
Other specified special examinations
17.6
206.8
366
168
Z01.0
ICD-10 Finland
Examination of eyes and vision
47.6
172.1
235
38
Z03.80
ICD-10 Finland
Observation for other suspected diseases and conditions
352.3
164.3
187
*
N02BE01
ATC
paracetamol; systemic, rectal
3.1
161.8
1812
7480
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
678.2
161.2
180
*
J01DB01
ATC
cefalexin; oral
2.9
142.7
1793
7667
A02BC02
ATC
pantoprazole; systemic
3.0
141.7
1311
4593
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
37.0
133.4
191
39
Z00.0
ICD-10 Finland
General medical examination
9.1
130.1
311
269
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.5
128.4
767
1932
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
60.9
118.1
155
19
Z01.1
ICD-10 Finland
Examination of ears and hearing
16.2
108.9
197
92
R07.4
ICD-10 Finland
Chest pain, unspecified
3.6
103.9
573
1322
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.6
98.4
541
1240
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
169.1
97.1
115
5
Z3231
NOMESCO Finland
Registered nurse
3.5
95.6
541
1268
N03AX16
ATC
pregabalin; oral
4.2
94.5
426
819
C07AB07
ATC
bisoprolol; oral
2.5
93.1
1015
3651
N06AX11
ATC
mirtazapine; oral
3.0
91.8
677
1918
N05AH04
ATC
quetiapine; oral
3.8
90.6
459
977
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
24.9
89.7
141
42
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
349.4
84.0
96
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.5
81.6
878
3084
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
75.4
80.8
103
10
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.7
76.4
668
2073
L28
ICPC
Limited function/disability (L)
4.7
75.9
296
487
S18
ICPC
Laceration/cut
2.8
71.7
575
1685
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.0
70.1
490
1310
I10
ICD-10 Finland
Essential (primary) hypertension
2.2
70.0
1007
4017
AA1AD
NOMESCO Finland
CT of head and brain
3.2
68.9
429
1057
R53
ICD-10 Finland
Malaise and fatigue
2.8
66.9
510
1442
UJF32
NOMESCO Finland
Coloscopy
3.2
66.3
418
1038
A02BC05
ATC
esomeprazole; systemic
2.4
66.2
710
2440
J01MA02
ATC
ciprofloxacin; systemic
2.2
64.8
883
3407
XKD00
NOMESCO Finland
Uroflowmetry
3.5
63.7
353
794
J01CA04
ATC
amoxicillin; systemic
2.0
62.0
1681
8576
SPAT1216
SPAT
Assessment of functional ability
4.8
61.9
233
367
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
4.6
61.6
243
402
UKC02
NOMESCO Finland
Cystoscopy
3.0
61.3
412
1064
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.2
61.2
378
922
A28
ICPC
Limited function/disability NOS
3.8
60.9
295
593
N06AB10
ATC
escitalopram; oral
3.0
60.0
405
1049
R06.0
ICD-10 Finland
Dyspnoea
2.8
59.5
460
1303
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.2
59.5
771
2884
M79.6
ICD-10 Finland
Pain in limb
2.7
59.3
497
1478
A98
ICPC
Health maint/preventive medicine
2.0
58.8
1707
8847
N02AA05
ATC
oxycodone; systemic
3.5
58.8
312
676
WX110
NOMESCO Finland
Local anesthesy
2.0
58.2
1200
5450
ZXD10
NOMESCO Finland
Scheduled procedure
2.3
57.8
673
2386
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
3.3
57.1
328
756
Z09.4
ICD-10 Finland
Follow-up examination after treatment of fracture
101.2
56.8
70
5
N02AX02
ATC
tramadol; systemic, rectal
2.1
55.9
876
3542
G04CA02
ATC
tamsulosin; oral
2.2
55.1
714
2652
A04
ICPC
Weakness/tiredness general
4.2
54.7
237
429
N03AX12
ATC
gabapentin; oral
3.8
54.4
265
533
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
5.6
54.2
177
236
ZXD05
NOMESCO Finland
Urgent procedure
2.3
53.1
637
2276
M01AH05
ATC
etoricoxib; oral
2.0
53.1
953
4057
J01AA02
ATC
doxycycline; systemic
1.9
52.8
1653
8636
Z2221
NOMESCO Finland
Medical doctor
2.7
52.7
430
1251
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.2
52.4
317
756
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.7
51.7
259
533
C10AA01
ATC
simvastatin; oral
2.2
51.2
690
2594
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.0
51.2
883
3688
SPAT1249
SPAT
Treatment-related counselling outside office
2.5
50.0
482
1538
SPAT1301
SPAT
No procedures
2.5
49.9
469
1475
SPAT1254
SPAT
Administration of medicine
3.4
49.6
275
612
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.4
49.2
274
613
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
3.2
48.5
288
677
M01AB05
ATC
diclofenac; systemic, rectal
1.8
47.6
1310
6440
215
Kela drug reimbursment
Diabetes, non-insulin-treated
3.1
47.6
301
739
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
3.0
47.6
317
807
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.3
47.6
277
641
TKE00
NOMESCO Finland
Needle biopsy of prostate
4.9
47.4
172
259
R42
ICD-10 Finland
Dizziness and giddiness
2.7
47.1
382
1102
H02AB06
ATC
prednisolone; systemic
2.0
47.1
887
3805
B01AB05
ATC
enoxaparin; parenteral
2.8
46.5
348
956
SAA01
NOMESCO Finland
Simple examination of mouth
1.8
46.4
1190
5695
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.5
46.3
414
1262
M54.5
ICD-10 Finland
Low back pain
2.3
45.2
519
1798
N40
ICD-10 Finland
Hyperplasia of prostate
2.2
45.1
544
1931
L17
ICPC
Foot/toe symptom/complaint
3.2
44.5
274
658
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.7
44.3
341
950
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.6
44.2
225
468
R51.80
ICD-10 Finland
Headache
3.4
44.2
244
542
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
44.1
371
1089
C09AA05
ATC
ramipril; oral
2.3
43.9
486
1654
K02.1
ICD-10 Finland
Caries of dentine
1.9
43.8
1014
4656
ZXA05
NOMESCO Finland
Left side
2.4
43.8
462
1534
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
2.7
43.6
353
1015
XF404
NOMESCO Finland
Ambulatory ECG
4.8
43.5
162
251
N06AX16
ATC
venlafaxine; oral
3.5
42.8
224
476
C08CA01
ATC
amlodipine; oral
2.2
42.6
560
2061
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.4
42.5
428
1385
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
179.5
42.4
50
*
T36
ICD-10 Finland
Poisoning by systemic antibiotics
6.4
42.3
123
141
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
42.3
387
1192
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
2.0
42.2
662
2624
N05BA04
ATC
oxazepam; oral
2.2
41.8
524
1883
J01MA12
ATC
levofloxacin; systemic
2.5
41.8
393
1226
SPAT1222
SPAT
Counselling/guidance promoting independent living
3.4
41.7
233
520
R4110
NOMESCO Finland
Physiotherapy
2.5
41.7
368
1110
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.1
41.3
573
2154
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.5
40.9
214
455
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
8.6
40.6
97
82
R03AC02
ATC
salbutamol; inhalant
1.8
40.2
946
4332
WX002
NOMESCO Finland
Sedation and analgesia
3.0
39.9
258
640
SPAT1263
SPAT
Sampling
2.0
39.6
651
2619
X59
ICD-10 Finland
Exposure to unspecified factor
2.4
39.3
383
1216
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.1
39.2
242
582
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
39.1
554
2095
N05CF01
ATC
zopiclone; oral
1.9
39.1
807
3529
P20
ICPC
Memory disturbance
4.0
38.7
174
325
M01AE01
ATC
ibuprofen; systemic, rectal
1.8
38.4
1854
10555
A29
ICPC
General symptom/complaint other
3.9
38.3
175
331
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
6.2
38.1
113
133
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.4
38.0
389
1265
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.6
38.0
195
408
XCK10
NOMESCO Finland
Photography of fundus of eye
4.3
38.0
155
264
XCW99
NOMESCO Finland
Other investigative procedure of eye
4.2
37.6
157
273
XF400
NOMESCO Finland
ECG with 12 standard connections
2.3
37.6
415
1401
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.8
37.5
886
4043
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
4.2
37.5
159
281
N05AH03
ATC
olanzapine; systemic
4.1
37.0
162
295
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.3
36.8
207
464
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.9
36.5
255
666
ZXE00
NOMESCO Finland
One hour or less
2.0
36.3
612
2471
G04CA01
ATC
alfuzosin; oral
2.6
36.3
301
873
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
31.7
36.3
53
12
ZXA00
NOMESCO Finland
Right side
2.1
36.2
464
1674
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
4.6
35.0
135
217
AN1
HP
Coronary angiography
3.4
35.0
192
423
N02AJ06
ATC
codeine and paracetamol; systemic
2.0
34.9
532
2064
XF402
NOMESCO Finland
ECG with work load test
3.8
34.7
161
309
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
7.2
34.6
92
93
M03BX02
ATC
tizanidine; oral
1.7
34.6
1027
5003
Z00.8
ICD-10 Finland
Other general examinations
6.3
34.5
101
117
KMAK
NOMESCO Finland
NA
1.7
34.4
930
4402
Z3226
NOMESCO Finland
Physiotherapist
2.7
34.3
269
754
M25.5
ICD-10 Finland
Pain in joint
2.4
34.1
336
1069
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
4.3
34.0
139
237
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
3.5
34.0
179
382
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.8
33.9
782
3512
XA402
NOMESCO Finland
ENMG
31.9
33.6
49
11
S06.0
ICD-10 Finland
Concussion
2.8
33.6
239
631
R33
ICD-10 Finland
Retention of urine
2.7
33.5
263
736
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.0
33.5
552
2201
T90
ICPC
Diabetes non-insulin dependent
2.8
33.5
241
641
C10AA05
ATC
atorvastatin; oral
2.1
33.2
460
1710
N06AX21
ATC
duloxetine; oral
3.9
33.2
151
285
L03
ICPC
Low back symptom/complaint
2.6
33.1
281
822
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
3.5
33.1
173
367
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.7
33.1
264
747
Z71.8
ICD-10 Finland
Other specified counselling
2.6
32.9
277
808
SAA02
NOMESCO Finland
Basic examination of mouth
1.7
32.8
1007
4932
J01CE02
ATC
phenoxymethylpenicillin; oral
1.6
32.8
1365
7281
R10.1
ICD-10 Finland
Pain localized to upper abdomen
3.0
32.7
211
522
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
6.0
32.6
98
118
Z01.2
ICD-10 Finland
Dental examination
2.0
32.6
535
2127
A02BC03
ATC
lansoprazole; oral
1.9
32.5
579
2375
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
3.0
32.3
209
518
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
32.3
768
3477
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
4.0
32.0
140
255
J01FA10
ATC
azithromycin; systemic
1.7
31.8
950
4603
C07AA05
ATC
propranolol; systemic
2.4
31.5
307
969
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
4.1
31.0
134
241
M01AE02
ATC
naproxen; oral, rectal
1.7
30.9
942
4581
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.4
30.9
292
907
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
4.6
30.7
118
189
R01AD09
ATC
mometasone; nasal
1.8
30.7
650
2825
E0000UV
ATC
NA
1.8
30.6
631
2715
Z04.3
ICD-10 Finland
Examination and observation following other accident
57.2
30.5
40
5
XQ800
NOMESCO Finland
Prick test
6.9
30.5
83
87
L29
ICPC
Musculoskeletal sympt/complt other
5.6
30.4
97
126
N06AB04
ATC
citalopram; systemic
2.0
30.3
468
1811
UJF30
NOMESCO Finland
Ileoscopy through colon
4.6
30.3
115
182
R31
ICD-10 Finland
Unspecified haematuria
2.6
30.1
240
676
B01AC04
ATC
clopidogrel; oral
2.6
30.0
240
679
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.9
30.0
208
540
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.7
29.9
146
293
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
5.0
29.7
105
154
M01AC06
ATC
meloxicam; systemic, rectal
1.9
29.7
538
2212
G47.3
ICD-10 Finland
Sleep apnoea
2.3
29.6
327
1097
ZX120
NOMESCO Finland
Intravenous
3.5
29.5
150
311
N05CF02
ATC
zolpidem; oral
2.5
29.4
269
819
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.7
29.4
822
3885
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
3.4
29.3
155
332
S01BC05
ATC
ketorolac; ophthalmic
3.3
29.3
162
359
H25.1
ICD-10 Finland
Senile nuclear cataract
1.9
29.2
553
2306
WX320
NOMESCO Finland
Spinalanesthesy
2.4
29.2
268
819
N05BA12
ATC
alprazolam; oral
2.9
29.1
195
495
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.4
29.0
279
873
N05AX08
ATC
risperidone; systemic
2.4
28.5
279
882
SPAT1053
SPAT
Memory test
3.4
28.4
153
332
A10AE04
ATC
insulin glargine; parenteral
3.1
28.2
174
418
DFF00
NOMESCO Finland
Pure tone audiometry
7.2
28.1
74
74
C61
ICD-10 Finland
Malignant neoplasm of prostate
2.4
28.1
271
849
R55
ICD-10 Finland
Syncope and collapse
2.5
28.0
247
737
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.5
28.0
107
171
WX892
NOMESCO Finland
Monitored bed care
3.8
27.6
127
242
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.8
27.6
100
151
R06AE07
ATC
cetirizine; oral
1.7
27.6
690
3145
M54.4
ICD-10 Finland
Lumbago with sciatica
2.7
27.3
214
598
ZXA10
NOMESCO Finland
Bilateral
2.4
27.1
248
756
SPAT1310
SPAT
Counselling related to known health issue
2.1
27.1
340
1206
A06AC01
ATC
ispaghula (psylla seeds); oral
2.1
26.9
370
1363
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.6
26.7
913
4538
SPAT1305
SPAT
Counselling and guidance related to physical exercise
3.9
26.7
121
228
R02
ICPC
Shortness of breath/dyspnoea
3.4
26.7
141
302
X58
ICD-10 Finland
Exposure to other specified factors
2.3
26.6
285
938
J01DA01
ATC
[U] cefalexin; systemic
1.6
26.5
1436
8007
N06AB06
ATC
sertraline; oral
2.9
26.5
175
438
M17.1
ICD-10 Finland
Other primary gonarthrosis
2.6
26.5
209
585
R50.9
ICD-10 Finland
Fever, unspecified
2.3
26.4
272
878
P15
ICPC
Chronic alcohol abuse
5.1
26.4
90
127
JN4BD
NOMESCO Finland
Extensive body CT
3.8
26.3
123
238
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.9
26.3
494
2046
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.5
26.2
225
661
SPAT1312
SPAT
General health counselling
2.1
26.1
345
1249
Z3229
NOMESCO Finland
Other healthcare associate professional
2.9
26.1
173
434
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
2.6
26.1
210
594
N07BB01
ATC
disulfiram; oral
3.6
25.9
126
252
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.1
25.9
155
364
SAA03
NOMESCO Finland
Extended examination of mouth
1.8
25.5
585
2586
-1
NOMESCO Finland
NA
1.8
25.5
530
2272
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
2.6
25.4
201
565
EBA00
NOMESCO Finland
Extraction of tooth
1.8
25.4
523
2233
J01FF01
ATC
clindamycin; systemic
1.9
25.3
461
1888
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.5
25.2
227
684
N03AX09
ATC
lamotrigine; oral
5.2
25.1
84
116
L15
ICPC
Knee symptom/complaint
2.7
25.1
187
507
N03AE01
ATC
clonazepam; systemic
3.7
25.1
120
237
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.6
25.0
93
145
R5140
NOMESCO Finland
Monitoring the use of the aid
2.8
24.8
174
454
SPAT1215
SPAT
Assessment of need for medical rehabilitation
6.7
24.7
68
73
H91.1
ICD-10 Finland
Presbycusis
3.2
24.6
144
333
A46
ICD-10 Finland
Erysipelas
2.2
24.6
267
885
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
24.5
27
*
I50.9
ICD-10 Finland
Heart failure, unspecified
1.8
24.5
474
1981
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
5.4
24.4
79
105
N05BA01
ATC
diazepam; systemic, rectal
2.1
24.4
304
1072
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
3.1
24.4
150
358
R60.0
ICD-10 Finland
Localized oedema
3.2
24.1
141
326
F41.1
ICD-10 Finland
Generalized anxiety disorder
5.0
24.1
83
119
SPAT1153
SPAT
Removal of sutures
2.1
23.9
313
1128
XG410
NOMESCO Finland
Flow-volume spirometry
6.8
23.8
65
69
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
23.8
756
3660
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.1
23.8
145
345
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
3.5
23.8
119
244
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.7
23.8
559
2482
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
2.6
23.8
187
523
Z97.4
ICD-10 Finland
Presence of external hearing-aid
3.9
23.7
107
201
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
3.7
23.7
112
219
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.0
23.7
353
1340
TKC20
NOMESCO Finland
Catheterisation of bladder
2.7
23.3
170
455
SPAT1360
SPAT
Extensive global examination
3.8
23.3
107
204
E000001
ATC
NA
2.0
23.3
354
1351
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.2
23.2
131
295
L01
ICPC
Neck symptom/complaint
3.3
23.1
129
288
P01AB01
ATC
metronidazole; oral, rectal
1.7
23.1
532
2344
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.2
23.1
95
164
N06AX12
ATC
bupropion; oral
3.6
23.1
113
228
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
6.2
23.0
67
78
K59.09
ICD-10 Finland
Constipation, unspecified
4.6
23.0
86
135
Z2446
NOMESCO Finland
Social worker
3.2
22.8
130
295
XA420
NOMESCO Finland
Extensive sleep examination
25.0
22.8
35
10
P01
ICPC
Feeling anxious/nervous/tense
3.2
22.7
131
299
C03CA01
ATC
furosemide; systemic
1.6
22.7
827
4140
M03BC01
ATC
orphenadrine (citrate); systemic
2.0
22.6
345
1318
K30
ICD-10 Finland
Functional dyspepsia
3.2
22.6
128
289
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.0
22.6
140
336
SPAT1234
SPAT
Support of social functional capacity
4.1
22.5
95
168
SPAT1229
SPAT
Assessment of need for aid
3.9
22.5
99
182
M48.0
ICD-10 Finland
Spinal stenosis
2.9
22.5
146
363
Z50.1
ICD-10 Finland
Other physical therapy
4.8
22.4
81
123
S29
ICPC
Skin symptom/complaint other
2.7
22.3
166
449
ZY010
NOMESCO Finland
Hospital outpatient
4.9
22.3
78
114
M01AX17
ATC
nimesulide; oral
1.9
22.3
405
1651
L13
ICPC
Hip symptom/complaint
3.7
22.3
106
209
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
2.2
22.2
255
864
J05AB01
ATC
aciclovir; systemic
2.1
22.2
297
1078
SPAT1325
SPAT
Vaccination
2.0
22.2
331
1254
J01FA06
ATC
roxithromycin; oral
1.6
22.1
752
3691
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.7
22.1
586
2688
JN3AD
NOMESCO Finland
Abdominal CT examination
3.7
22.1
106
210
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
5.5
21.9
70
92
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.7
21.9
559
2536
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
7.6
21.8
55
52
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.7
21.8
554
2509
M01AX05
ATC
glucosamine; oral
2.4
21.8
195
586
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
5.5
21.7
69
90
WX290
NOMESCO Finland
Other blockade of nerve
1.6
21.7
762
3767
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.0
21.7
325
1232
T89
ICPC
Diabetes insulin dependent
4.4
21.7
85
140
H03AA01
ATC
levothyroxine sodium; systemic
2.2
21.6
235
777
D07AD01
ATC
clobetasol; topical
2.4
21.6
200
613
J01FA09
ATC
clarithromycin; systemic
1.8
21.5
458
1965
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.5
21.4
107
220
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.8
21.3
146
375
M03BC51
ATC
orphenadrine, combinations; systemic
1.8
21.3
402
1657
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.2
21.3
242
816
L08
ICPC
Shoulder symptom/complaint
2.5
21.3
187
557
N03AG01
ATC
valproic acid; systemic, rectal
3.3
21.3
117
258
R52.2
ICD-10 Finland
Other chronic pain
7.0
21.2
56
57
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
3.0
21.1
130
312
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
3.1
21.1
125
292
F51.0
ICD-10 Finland
Nonorganic insomnia
2.5
21.1
180
528
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
21.0
264
932
R35
ICD-10 Finland
Polyuria
3.8
20.9
97
187
R05
ICD-10 Finland
Cough
2.4
20.9
190
576
-69
ICPC
Other reason for encounter NEC
5.7
20.9
64
80
C10AA07
ATC
rosuvastatin; oral
2.3
20.9
221
721
U05
ICPC
Urination problems other
5.2
20.8
69
95
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.9
20.8
366
1473
SPAT1211
SPAT
Application of soft bandage
3.5
20.8
104
214
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
3.6
20.7
102
207
K78
ICPC
Atrial fibrillation/flutter
3.9
20.7
92
171
SPAT1172
SPAT
Guidance concerning hydration
7.2
20.7
54
54
C09CA06
ATC
candesartan; oral
2.1
20.6
267
955
C09CA01
ATC
losartan; oral
2.0
20.6
313
1194
G04BD12
ATC
mirabegron; oral
4.8
20.5
73
109
A11
ICPC
Chest pain NOS
4.2
20.4
83
142
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.8
20.4
384
1580
H13
ICPC
Plugged feeling ear
2.4
20.4
189
579
-50
ICPC
Medication/prescr/renewal
4.7
20.4
74
113
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
5.7
20.3
63
80
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.5
20.3
170
494
Z09.8
ICD-10 Finland
Follow-up examination after other treatment for other conditions
88.9
20.2
25
*
XJH00
NOMESCO Finland
Transanal ultrasonography
2.7
20.2
151
411
A99
ICPC
Disease/condition unspecnature/site
3.8
20.1
91
172
SPAT1260
SPAT
Consultation of another employee
2.4
20.1
179
536
R5120
NOMESCO Finland
Preparation of an aid
6.0
20.1
59
70
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
4.7
20.0
73
112
H29
ICPC
Ear symptom/complaint other
3.5
20.0
99
202
R03BB04
ATC
tiotropium bromide; inhalant
2.2
20.0
227
768
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
20.7
19.9
32
11
N30.0
ICD-10 Finland
Acute cystitis
2.7
19.8
148
403
C08CA13
ATC
lercanidipine; oral
2.6
19.7
154
430
A10AE05
ATC
insulin detemir; parenteral
3.6
19.7
95
190
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.6
19.5
96
195
S01.0
ICD-10 Finland
Open wound of scalp
2.4
19.5
181
555
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
8.7
19.5
45
37
F29
ICD-10 Finland
Unspecified nonorganic psychosis
3.5
19.4
99
207
Z76.0
ICD-10 Finland
Issue of repeat prescription
2.3
19.4
197
631
Z00.6
ICD-10 Finland
Examination for normal comparison and control in clinical research programme
46.2
19.4
26
*
R05
ICPC
Cough
2.2
19.4
209
690
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
7.5
19.3
49
47
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.3
19.3
104
227
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.7
19.2
147
404
DFF15
NOMESCO Finland
Speech audiometry
11.1
19.2
39
25
N06AB03
ATC
fluoxetine; oral
2.3
19.2
189
597
R74
ICPC
Upper respiratory infection acute
1.8
19.1
375
1563
TK800
NOMESCO Finland
Hemodialysis
7.3
19.1
49
48
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.3
19.0
103
226
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
19.0
267
987
D64.9
ICD-10 Finland
Anaemia, unspecified
2.2
18.9
217
735
NF1AA
NOMESCO Finland
Hip X-ray examination
3.2
18.9
105
234
R21
ICPC
Throat symptom/complaint
2.1
18.9
240
850
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.9
18.9
124
310
M01AH01
ATC
celecoxib; oral (coxibs)
2.0
18.9
254
921
Z01.7
ICD-10 Finland
Laboratory examination
3.0
18.8
117
283
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
2.7
18.8
139
376
J45.9
ICD-10 Finland
Asthma, unspecified
2.0
18.8
255
929
R00.2
ICD-10 Finland
Palpitations
3.8
18.7
86
165
SPAT1262
SPAT
Handing over of treatment supplies
2.2
18.7
202
666
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
4.6
18.6
69
108
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.9
18.4
121
302
H25.8
ICD-10 Finland
Other senile cataract
2.2
18.3
202
673
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
3.1
18.3
108
252
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
6.1
18.3
53
62
R01AD08
ATC
fluticasone; nasal
1.7
18.2
424
1861
127
Kela drug reimbursment
Transplant complication
13.5
18.2
34
18
G44.2
ICD-10 Finland
Tension-type headache
2.7
18.2
135
365
N17
ICPC
Vertigo/dizziness
3.5
18.1
92
192
R13
ICD-10 Finland
Dysphagia
3.4
18.1
94
200
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
4.6
18.0
66
102
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.6
18.0
140
389
R20.2
ICD-10 Finland
Paraesthesia of skin
3.5
18.0
89
182
F34.1
ICD-10 Finland
Dysthymia
5.2
17.9
59
81
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
6.6
17.9
49
53
A01
ICPC
Pain general/multiple sites
3.5
17.9
90
187
SPAT1097
SPAT
Recording of ECG
2.6
17.8
145
413
J01MA14
ATC
moxifloxacin; systemic
2.5
17.8
145
415
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.6
17.7
84
166
XCK00
NOMESCO Finland
Perimetry
3.6
17.7
84
166
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.6
17.7
484
2226
CJB10
NOMESCO Finland
Laser discission of secondary cataract
2.8
17.6
122
317
L02AE02
ATC
leuprorelin; implant, parenteral
3.0
17.5
112
275
R29
ICPC
Respiratory symptom/complaint other
3.8
17.5
79
150
R07.3
ICD-10 Finland
Other chest pain
2.6
17.4
141
402
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
5.4
17.4
56
75
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
5.4
17.4
56
75
H81
ICPC
Excessive ear wax
2.3
17.3
177
570
SPAT1281
SPAT
Other administrative function
3.5
17.3
87
181
WZA90
NOMESCO Finland
Other doctors statement
1.9
17.2
283
1109
SPAT1167
SPAT
Insertion of urinary catheter
5.0
17.2
59
85
ZXE20
NOMESCO Finland
More than three and less than five hours
2.2
17.2
187
617
A03
ICPC
Fever
2.0
17.2
241
888
G04CA52
ATC
tamsulosin and dutasteride; systemic
3.2
17.2
96
216
M79.1
ICD-10 Finland
Myalgia
2.6
17.0
134
376
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.8
17.0
302
1217
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
4.1
16.9
71
126
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
1.8
16.9
316
1294
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
4.6
16.8
62
97
A10BH01
ATC
sitagliptin; oral
3.1
16.8
98
226
G04BD08
ATC
solifenacin; oral
3.4
16.7
85
178
G04CB02
ATC
dutasteride; oral
3.0
16.7
103
248
R01AD12
ATC
fluticasone furoate; nasal
1.7
16.7
358
1531
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.3
16.5
166
528
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
6.2
16.5
47
54
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.9
16.5
284
1131
R52.9
ICD-10 Finland
Pain, unspecified
3.0
16.5
100
239
R01BA52
ATC
pseudoephedrine, combinations; oral
1.7
16.5
394
1742
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
3.2
16.5
93
211
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
7.5
16.4
41
39
WX872
NOMESCO Finland
Intensive care
4.0
16.3
70
127
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.9
16.3
72
134
Z03.4
ICD-10 Finland
Observation for suspected myocardial infarction
+∞
16.3
18
*
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
16.6
16.3
28
12
H26.4
ICD-10 Finland
After-cataract
2.4
16.3
150
458
R03DC03
ATC
montelukast; oral
2.1
16.3
188
640
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
4.3
16.3
64
107
F90.0
ICD-10 Finland
Disturbance of activity and attention
4.7
16.2
58
88
D07AC13
ATC
mometasone; topical
1.6
16.2
446
2049
J02AC01
ATC
fluconazole; systemic
1.8
16.2
328
1379
N05AX12
ATC
aripiprazole; systemic
3.5
16.1
79
161
P76
ICPC
Depressive disorder
3.4
16.1
83
176
P29
ICPC
Psychological sympt/compl other
3.4
16.1
83
176
Z01.9
ICD-10 Finland
Special examination, unspecified
5.8
16.0
48
59
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
3.0
16.0
97
232
B18.2
ICD-10 Finland
Chronic viral hepatitis C
6.4
15.8
44
49
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
3.9
15.8
68
124
N04BC05
ATC
pramipexole; oral
3.1
15.8
91
210
D19
ICPC
Teeth/gum symptom/complaint
1.8
15.8
315
1318
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.6
15.8
76
153
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.6
15.7
75
150
XF600
NOMESCO Finland
Bloodpressure measurement
3.1
15.6
93
219
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.8
15.6
105
267
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
4.5
15.6
59
95
J01AA04
ATC
lymecycline; systemic
2.1
15.6
191
665
K85
ICPC
Elevated blood pressure
2.6
15.6
120
333
N06AX26
ATC
vortioxetine; oral
3.1
15.6
92
215
P03
ICPC
Feeling depressed
2.8
15.6
107
278
F31.8
ICD-10 Finland
Other bipolar affective disorders
9.3
15.5
34
26
Z94.0
ICD-10 Finland
Kidney transplant status
14.2
15.5
28
14
TPH07
NOMESCO Finland
Cathetrisation of artery
2.6
15.4
118
325
A06AC51
ATC
ispaghula, combinations; systemic
4.1
15.4
63
110
L04AA06
ATC
mycophenolic acid; systemic
11.0
15.4
31
20
M02AA10
ATC
ketoprofen; topical
1.9
15.3
240
921
SPAT1100
SPAT
Long-term monitoring of blood pressure
3.1
15.3
88
203
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.3
15.2
84
186
M10.9
ICD-10 Finland
Gout, unspecified
2.8
15.2
107
281
SPAT1252
SPAT
Overall medication plan or its review
3.3
15.2
80
173
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
21.3
15.2
24
8
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.6
15.1
120
339
M54.2
ICD-10 Finland
Cervicalgia
3.1
15.1
87
201
-34
ICPC
Blood test
4.9
15.1
52
76
L57.0
ICD-10 Finland
Actinic keratosis
2.7
15.0
107
284
SPAT1359
SPAT
Use of symptom diary
12.1
15.0
29
17
H04.10
ICD-10 Finland
Dry eye syndrome
3.4
15.0
78
167
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.9
15.0
255
1010
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
3.0
14.9
93
225
SDE03
NOMESCO Finland
Periodontal treatment by dental hygienist, extensive
1.7
14.9
320
1368
R2110
NOMESCO Finland
Giving the first information
4.2
14.9
59
100
Z02.7
ICD-10 Finland
Issue of medical certificate
3.0
14.8
93
227
A02BC01
ATC
omeprazole; systemic
1.6
14.8
498
2406
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.0
14.7
193
694
S97
ICPC
Chronic ulcer skin
3.8
14.7
65
122
D07AC01
ATC
betamethasone; topical
1.5
14.7
521
2549
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.5
14.6
765
4069
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
3.9
14.6
64
119
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.6
14.5
116
329
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.9
14.5
95
239
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.8
14.5
99
256
N06AB05
ATC
paroxetine; oral
3.1
14.4
86
203
Z51.5
ICD-10 Finland
Palliative care
3.8
14.4
65
124
TAB00
NOMESCO Finland
Lumbar puncture
4.0
14.4
60
107
D07AB02
ATC
hydrocortisone butyrate; topical
1.6
14.3
458
2181
D82
ICPC
Teeth/gum disease
1.6
14.3
440
2077
M16.1
ICD-10 Finland
Other primary coxarthrosis
2.4
14.3
126
376
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
3.0
14.2
87
210
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
3.3
14.2
74
159
Z03.0
ICD-10 Finland
Observation for suspected tuberculosis
120.5
14.2
17
*
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
5.0
14.2
48
69
M54
ICD-10 Finland
Dorsalgia
2.2
14.2
160
540
KED22
NOMESCO Finland
Transurethral resection of prostate
2.1
14.1
170
588
Z49.0
ICD-10 Finland
Preparatory care for dialysis
22.3
14.1
22
7
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.6
14.1
377
1714
K90
ICPC
Stroke/cerebrovascular accident
6.0
14.1
41
49
R06AX22
ATC
ebastine; oral
1.9
14.1
228
886
F29
ICPC
Eye symptom/complaint other
3.2
14.0
78
175
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.0
14.0
86
208
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.3
14.0
75
165
UJF92
NOMESCO Finland
Capsular endoscopy
10.3
14.0
29
20
G56.2
ICD-10 Finland
Lesion of ulnar nerve
4.0
14.0
58
103
F10.09
ICD-10 Finland
Alcohol intoxication UNS
4.5
14.0
52
83
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
2.2
13.9
158
534
N06AX22
ATC
agomelatine; oral
6.1
13.9
40
47
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
3.1
13.9
80
185
H91.9
ICD-10 Finland
Hearing loss, unspecified
4.3
13.9
54
90
N06DX01
ATC
memantine; oral
2.1
13.8
161
549
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
2.5
13.8
117
342
S21
ICPC
Skin texture symptom/complaint
2.6
13.8
108
302
D11
ICPC
Diarrhoea
2.3
13.8
140
449
R05FA02
ATC
opium derivatives and expectorants; systemic
1.5
13.7
666
3481
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
5.7
13.7
41
51
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
3.8
13.7
60
112
M02AA07
ATC
piroxicam; topical
1.5
13.7
628
3246
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
3.5
13.6
67
138
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.7
13.6
311
1352
R11
ICD-10 Finland
Nausea and vomiting
2.3
13.6
132
415
SPAT1240
SPAT
Therapeutic discussion
2.3
13.5
137
440
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
3.2
13.5
75
168
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
4.3
13.5
52
86
D01BA02
ATC
terbinafine; oral; topical
1.6
13.5
360
1635
W00
ICD-10 Finland
Fall on same level involving ice and snow
2.1
13.4
163
567
H04AA01
ATC
glucagon; nasal, parenteral
4.0
13.4
56
100
-60
ICPC
Result test/procedure
3.6
13.4
63
125
D07CC01
ATC
betamethasone and antibiotics; topical
1.9
13.4
208
797
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
3.2
13.4
74
165
U02
ICPC
Urinary frequency/urgency
3.7
13.4
61
118
G56.0
ICD-10 Finland
Carpal tunnel syndrome
2.3
13.4
128
400
R81
ICPC
Pneumonia
4.3
13.3
52
87
N07CA01
ATC
betahistine; oral
2.4
13.3
118
355
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.3
13.3
71
156
L16
ICPC
Ankle symptom/complaint
2.8
13.3
92
240
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
3.4
13.3
67
141
DAX08
NOMESCO Finland
Fitting of hearing aid
6.3
13.3
37
42
M01AH02
ATC
rofecoxib; oral
1.9
13.3
196
739
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.2
13.2
137
444
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
3.8
13.2
59
112
L12
ICPC
Hand/finger symptom/complaint
2.3
13.2
132
421
R03AK07
ATC
formoterol and budesonide; inhalant
1.8
13.2
261
1087
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
3.0
13.2
80
192
F10.24
ICD-10 Finland
Alcohol depence active use
6.0
13.2
38
45
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.0
13.1
189
704
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
17.4
13.1
22
9
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.4
13.1
119
363
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
4.2
13.1
52
89
R23.8
ICD-10 Finland
Other and unspecified skin changes
2.3
13.0
123
381
WX100
NOMESCO Finland
Conjunctival surface anesthesia
3.1
13.0
75
174
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
3.8
13.0
58
110
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
2.7
13.0
91
240
S22.3
ICD-10 Finland
Fracture of rib
2.4
13.0
120
368
116
Kela drug reimbursment
Prostate cancer
2.1
13.0
162
572
SPAT1125
SPAT
Stoma care and guidance
7.9
12.9
31
28
N05AN01
ATC
lithium; oral
4.9
12.9
44
64
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
11.8
12.9
25
15
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
2.5
12.9
104
298
Z13.1
ICD-10 Finland
Special screening examination for diabetes mellitus
26.9
12.9
19
5
E11
ICD-10 Finland
Type 2 diabetes mellitus
2.1
12.9
146
494
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
18.6
12.9
21
8
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.5
12.8
109
321
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.6
12.8
61
123
SPAT1104
SPAT
Monitoring of emergency patient
2.9
12.8
79
193
K29.3
ICD-10 Finland
Chronic superficial gastritis
5.1
12.7
42
59
B01AB04
ATC
dalteparin; parenteral
3.2
12.7
70
156
N05BA06
ATC
lorazepam; systemic, sublingual
2.3
12.7
121
378
A06AD11
ATC
lactulose; oral
1.5
12.7
430
2074
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.5
12.6
616
3215
B01AF02
ATC
apixaban; oral
3.3
12.6
67
147
U07
ICPC
Urine symptom/complaint other
4.3
12.6
48
79
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
20.3
12.6
20
7
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
5.5
12.6
39
51
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.6
12.6
94
256
F32
ICD-10 Finland
Depressive episode
3.4
12.6
64
136
SPAT1283
SPAT
Restricted health certificate
1.8
12.5
243
1004
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.5
12.5
456
2235
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.9
12.5
54
100
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
4.2
12.5
49
83
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
6.0
12.5
36
43
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.6
12.5
95
264
SPAT1251
SPAT
Organisation of medication
2.9
12.4
79
195
E23.04
ICD-10 Finland
Hypogonadotropic hypogonadism
5.0
12.4
41
58
K07
ICPC
Swollen ankles/oedema
5.0
12.4
41
58
M54.1
ICD-10 Finland
Radiculopathy
4.4
12.4
47
77
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
3.8
12.4
54
101
B01AA03
ATC
warfarin; systemic
1.5
12.4
514
2593
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
2.9
12.3
76
185
P19
ICPC
Drug abuse
6.1
12.3
35
41
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.7
12.3
86
226
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.5
12.2
59
120
N06AX05
ATC
trazodone; oral
4.7
12.2
43
65
F41.09
ICD-10 Finland
UNS Panic Syndrome
4.7
12.2
43
65
XCH00
NOMESCO Finland
Eye pressure measurement
5.6
12.2
37
47
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
3.6
12.2
57
113
J31.0
ICD-10 Finland
Chronic rhinitis
2.7
12.2
86
228
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.3
12.2
115
357
C05AA08
ATC
fluocortolone; rectal, topical
1.9
12.2
202
794
N06DA02
ATC
donepezil; oral
2.1
12.2
147
510
I95.1
ICD-10 Finland
Orthostatic hypotension
3.0
12.2
71
167
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
6.2
12.1
34
39
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
3.0
12.1
73
174
S76
ICPC
Skin infection other
3.5
12.1
59
121
P74
ICPC
Anxiety disorder/anxiety state
4.0
12.1
50
89
S06
ICPC
Rash localized
3.4
12.1
60
125
U71
ICPC
Cystitis/urinary infection other
6.7
12.1
32
34
K77
ICPC
Heart failure
5.7
12.1
36
45
Y96.9
ICD-10 Finland
Unspecified type of accident
7.4
12.1
30
29
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
5.3
12.0
38
51
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
6.3
12.0
33
37
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.7
12.0
275
1197
XKD06
NOMESCO Finland
Physiologic investigation of micturition
4.5
12.0
44
70
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
2.6
11.9
91
253
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
3.6
11.9
56
112
-31
ICPC
Medical examin/health eval partial
2.8
11.9
77
194
W19
ICD-10 Finland
Unspecified fall
1.9
11.9
179
679
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
3.7
11.9
54
105
Z08
ICPC
Social welfare problem
10.7
11.8
24
16
A05
ICPC
Feeling ill
3.1
11.8
67
154
Z49.1
ICD-10 Finland
Extracorporeal dialysis
8.0
11.8
28
25
L14
ICPC
Leg/thigh symptom/complaint
3.5
11.8
58
120
TDM10
NOMESCO Finland
Puncture of maxillary antrum
3.6
11.8
55
109
NE1AA
NOMESCO Finland
Pelvis X-ray examination
2.7
11.8
81
212
D12
ICPC
Constipation
6.2
11.8
33
38
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
3.0
11.8
71
170
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.0
11.8
71
170
H93.1
ICD-10 Finland
Tinnitus
3.0
11.8
69
163
H02
ICPC
Hearing complaint
2.8
11.7
80
208
R12
ICD-10 Finland
Heartburn
2.8
11.7
77
196
B01AB10
ATC
tinzaparin; parenteral
3.6
11.7
55
110
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
7.4
11.7
29
28
ZY000
NOMESCO Finland
Hospital inpatient
7.4
11.7
29
28
J30.3
ICD-10 Finland
Other allergic rhinitis
4.2
11.6
46
79
H3600, E103
ICD-10 Finland
NA
6.9
11.6
30
31
L04AD01
ATC
ciclosporin; systemic
6.9
11.6
30
31
CKC12
NOMESCO Finland
Photocoagulation of retina
4.2
11.5
45
76
P16
ICPC
Acute alcohol abuse
4.6
11.5
41
63
EP1AE
NOMESCO Finland
Neck ultrasound examination
3.6
11.5
53
104
A10BA02
ATC
metformin; oral
1.5
11.5
406
1972
-42
ICPC
Electrical tracing
12.0
11.5
22
13
A03FA01
ATC
metoclopramide; systemic, rectal
1.7
11.4
249
1070
R06.5
ICD-10 Finland
Mouth breathing
2.2
11.4
122
404
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
4.8
11.3
39
58
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
7.4
11.3
28
27
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.3
11.3
112
357
P70
ICPC
Dementia
3.8
11.3
50
95
H3601, E103
ICD-10 Finland
NA
8.9
11.3
25
20
S04
ICPC
Lump/swelling localized
2.5
11.3
91
262
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
2.3
11.2
111
353
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
14.2
11.2
20
10
A97
ICPC
No disease
2.1
11.2
138
484
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
7.7
11.2
27
25
SPAT1304
SPAT
Counselling and guidance related to ageing
3.3
11.2
57
122
Z72.2
ICD-10 Finland
Drug use
10.2
11.2
23
16
K22
ICPC
Risk factor cardiovascular disease
4.3
11.2
43
72
GD1AD
NOMESCO Finland
Thorax CT examination
4.3
11.2
43
72
TQW99
NOMESCO Finland
Other minor procedure on skin
3.0
11.1
67
160
N01
ICPC
Headache
2.7
11.1
80
216
F10.20
ICD-10 Finland
Alcohol dependence currently independent
4.1
11.1
44
76
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.5
11.1
88
249
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
28.3
11.0
16
*
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
4.8
11.0
38
57
F61.0
ICD-10 Finland
Mixed personality disorders
5.6
11.0
33
42
B82
ICPC
Anaemia other/unspecified
6.7
11.0
29
31
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.2
10.9
59
132
4912B
ICD-9 Finland
Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]
0.3
10.9
19
488
M04AA01
ATC
allopurinol; systemic
1.6
10.9
277
1241
G30.1
ICD-10 Finland
Alzheimer disease with late onset
1.8
10.9
193
777
SPAT1245
SPAT
Provision of support and information to patient’s family members
3.3
10.8
57
125
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
1.7
10.8
253
1106
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.7
10.8
75
198
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.9
10.8
163
620
E66.8
ICD-10 Finland
Other obesity
3.7
10.8
48
92
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
5.5
10.8
33
43
TNX33
NOMESCO Finland
Custom moulded cast, unspecified region
2.6
10.8
80
218
R03BA05
ATC
fluticasone; inhalant
1.6
10.8
282
1274
J01EA01
ATC
trimethoprim; systemic
1.5
10.8
385
1875
K59.1
ICD-10 Finland
Functional diarrhoea
3.0
10.7
65
156
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
3.3
10.7
56
122
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
3.3
10.7
56
122
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
2.4
10.7
93
278
WX402
NOMESCO Finland
General anaesthesia
1.9
10.7
159
601
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.3
10.7
101
315
TKC22
NOMESCO Finland
Catheterisation instruction
8.1
10.7
25
22
A23
ICPC
Risk factor NOS
2.1
10.7
128
443
N30.9
ICD-10 Finland
Cystitis, unspecified
2.4
10.7
90
265
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
3.6
10.7
50
100
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.0
10.7
62
146
RD211
NOMESCO Finland
NA
6.1
10.7
30
35
N05BE01
ATC
buspirone; oral
3.3
10.7
55
119
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
2.7
10.6
74
196
E000006
ATC
NA
2.4
10.6
95
289
A56.0
ICD-10 Finland
Chlamydial infection of lower genitourinary tract
5.6
10.6
32
41
WW200
NOMESCO Finland
Immunization
4.8
10.6
36
53
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
2.9
10.5
68
170
WZC30
NOMESCO Finland
Teaching
2.4
10.5
91
271
H35.31
ICD-10 Finland
Senile macular degeneration (atrophic)(exudative)
2.6
10.5
77
210
H02AB07
ATC
prednisone; oral
1.6
10.5
272
1224
TFP20
NOMESCO Finland
Cardiodefibrillation
2.4
10.5
89
263
M54.6
ICD-10 Finland
Pain in thoracic spine
2.5
10.5
85
244
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
2.5
10.5
86
250
Z03
ICPC
Housing/neighbourhood problem
13.5
10.5
19
10
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
10.6
10.4
21
14
N06BA04
ATC
methylphenidate; oral
3.8
10.4
45
84
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.9
10.4
149
556
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
4.7
10.4
36
54
D20
ICPC
Mouth/tongue/lip symptom/complaint
4.3
10.4
40
67
R06AE09
ATC
levocetirizine; oral
1.9
10.4
171
670
A10AE06
ATC
insulin degludec; parenteral
3.6
10.4
48
95
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.9
10.4
150
559
T74.1
ICD-10 Finland
Physical abuse
4.0
10.4
42
74
Z2445
NOMESCO Finland
Psychologist
3.7
10.4
46
88
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
3.0
10.4
60
141
I49.5
ICD-10 Finland
Sick sinus syndrome
2.5
10.3
84
242
P99
ICPC
Psychological disorders other
3.6
10.3
47
92
F43.29
ICD-10 Finland
Adaptation disorder UNS
7.1
10.3
26
26
F41.00
ICD-10 Finland
Moderate panic disorder
7.1
10.3
26
26
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
3.9
10.3
43
78
SPAT1231
SPAT
Assessment of adjustments needed in living environment
6.1
10.3
29
34
SAA04
NOMESCO Finland
Special inverstigation of mouth
3.0
10.3
62
148
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.4
10.3
92
279
H02AB04
ATC
methylprednisolone; systemic
1.7
10.3
237
1034
UJD02
NOMESCO Finland
Gastroscopy
2.4
10.3
89
265
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
5.8
10.3
30
37
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
5.8
10.3
30
37
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
3.3
10.3
53
115
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
4.8
10.2
35
52
L82
ICD-10 Finland
Seborrhoeic keratosis
2.2
10.2
109
359
U29
ICPC
Urinary symptom/complaint other
5.5
10.2
31
40
S40.0
ICD-10 Finland
Contusion of shoulder and upper arm
2.8
10.2
70
182
D07BC01
ATC
betamethasone and antiseptics; topical
1.8
10.2
187
761
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
7.4
10.2
25
24
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
2.5
10.2
83
240
J20
ICD-10 Finland
Acute bronchitis
2.4
10.1
91
276
K04
ICPC
Palpitations/awareness of heart
4.1
10.1
40
69
B03BA03
ATC
hydroxocobalamin; parenteral
2.1
10.1
124
435
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
9.9
10.1
21
15
A11CC03
ATC
alfacalcidol; systemic
3.8
10.1
44
83
I44.1
ICD-10 Finland
Atrioventricular block, second degree
3.4
10.1
50
105
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
4.7
10.1
35
53
H84
ICPC
Presbyacusis
4.7
10.1
35
53
L76
ICPC
Fracture: other
4.8
10.1
34
50
TNX32
NOMESCO Finland
Custom moulded splint, unspecified region
2.9
10.0
65
163
L02
ICPC
Back symptom/complaint
2.5
10.0
83
243
M53.1
ICD-10 Finland
Cervicobrachial syndrome
2.2
10.0
106
350
SPAT1043
SPAT
Audiometry
2.8
10.0
67
174
R03BA08
ATC
ciclesonide; inhalant
2.6
10.0
74
204
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
1.9
10.0
151
576
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
8.2
10.0
23
20
H01
ICPC
Ear pain/earache
2.2
10.0
100
321
F06.7
ICD-10 Finland
Mild cognitive disorder
4.5
10.0
36
57
E66.01
ICD-10 Finland
Obesity due to excess calories
2.7
9.9
70
187
M54.8
ICD-10 Finland
Other dorsalgia
3.6
9.9
45
88
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.5
9.9
389
1932
F10.25
ICD-10 Finland
Alcohol dependence continuous use
3.9
9.9
41
74
K05.31
ICD-10 Finland
Periodontitis pronounced
2.3
9.9
95
299
TNX39
NOMESCO Finland
Other orthopedic bandage, unspecified region
5.7
9.9
29
36
SPAT1255
SPAT
Intravenous administration of medicine
2.5
9.9
78
221
NGB40
NOMESCO Finland
Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis
4.2
9.9
38
64
M05BA04
ATC
alendronic acid; oral
2.1
9.9
122
429
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
5.5
9.9
30
39
B02.9
ICD-10 Finland
Zoster without complication
3.0
9.9
60
145
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
2.8
9.9
64
161
S01GX01
ATC
cromoglicic acid; ophthalmic
1.7
9.8
223
967
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.4
9.8
48
100
NG1BA
NOMESCO Finland
Knee extensive X-ray examination
7.4
9.8
24
23
K04.08
ICD-10 Finland
Other specified pulpit
2.1
9.8
109
368
TPX10
NOMESCO Finland
Implantation of vascular injection port
3.7
9.8
43
82
J34.2
ICD-10 Finland
Deviated nasal septum
2.2
9.8
97
311
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
2.9
9.7
60
147
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
3.5
9.7
47
97
B81
ICPC
Anaemia vit B12/folate deficiency
4.0
9.7
40
72
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.8
9.7
64
164
R04.2
ICD-10 Finland
Haemoptysis
2.7
9.7
67
176
B03XA02
ATC
darbepoetin alfa; parenteral
4.9
9.7
32
46
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
5.3
9.7
30
40
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
5.1
9.7
31
43
A12AA04
ATC
calcium carbonate; oral
4.0
9.7
39
69
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.5
9.6
332
1603
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
6.4
9.6
26
29
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
4.1
9.6
38
66
NA1AD
NOMESCO Finland
Cervical spine CT examination
3.0
9.6
55
129
M02AA15
ATC
diclofenac; topical (antiinflammatory prep., non-steroids for topical use)
2.1
9.6
114
397
R60.9
ICD-10 Finland
Oedema, unspecified
3.2
9.6
50
110
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
3.1
9.6
54
125
M19.0
ICD-10 Finland
Primary arthrosis of other joints
2.5
9.5
76
217
R06AX27
ATC
desloratadine; oral
1.5
9.5
304
1442
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
4.8
9.5
32
47
N06AA04
ATC
clomipramine; systemic
5.4
9.5
29
38
M70.6
ICD-10 Finland
Trochanteric bursitis
3.6
9.5
44
88
Z71.4
ICD-10 Finland
Alcohol abuse counselling and surveillance
16.2
9.5
16
7
I25
ICD-10 Finland
Chronic ischaemic heart disease
2.9
9.5
59
146
S82
ICPC
Naevus/mole
2.3
9.5
92
291
R51
ICD-10 Finland
Headache
2.7
9.5
66
175
JN4AD
NOMESCO Finland
Body CT examination
2.9
9.4
58
142
R21
NOMESCO Finland
Counselling and guidance in rehabilitation
24.8
9.4
14
*
J45.1
ICD-10 Finland
Nonallergic asthma
2.3
9.4
89
278
F11.25
ICD-10 Finland
Relationship caused by opiates continuously used
13.4
9.4
17
9
XG405
NOMESCO Finland
Education on PEF monitoring
10.4
9.4
19
13
D07AA02
ATC
hydrocortisone; topical
1.6
9.4
239
1071
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.9
9.4
39
71
Z28
ICPC
Limited function/disability (Z)
11.6
9.4
18
11
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.0
9.4
116
408
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
3.0
9.4
57
138
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
6.8
9.3
24
25
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
3.0
9.3
55
132
R05FB02
ATC
cough suppressants and expectorants
1.3
9.3
699
3911
S19
ICPC
Skin injury other
3.1
9.3
53
124
H60.9
ICD-10 Finland
Otitis externa, unspecified
2.4
9.3
83
253
XW000
NOMESCO Finland
Bone marrow biopsy
3.7
9.3
41
79
G43.9
ICD-10 Finland
Migraine, unspecified
3.7
9.3
41
79
A10BH05
ATC
linagliptin; oral
3.7
9.3
41
79
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.7
9.2
65
174
C10AC01
ATC
colestyramine; oral
4.1
9.2
36
62
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.7
9.2
62
162
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
5.6
9.2
27
34
F33
ICD-10 Finland
Recurrent depressive disorder
5.6
9.2
27
34
K10.3
ICD-10 Finland
Alveolitis of jaws
3.1
9.2
52
121
OAA65
SPAT
NA
1.8
9.2
155
615
L10
ICPC
Elbow symptom/complaint
2.8
9.1
61
158
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
5.4
9.1
28
37
N20.1
ICD-10 Finland
Calculus of ureter
3.0
9.1
54
130
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
4.3
9.1
34
56
D01
ICPC
Abdominal pain/cramps general
2.4
9.1
79
237
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
3.3
9.1
47
103
F33.1
ICD-10 Finland
Recurrent depressive disorder, current episode moderate
4.1
9.1
36
63
TCG40
NOMESCO Finland
Measurement of higher-grade errors of refraction
+∞
9.1
10
*
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
+∞
9.1
10
*
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
3.2
9.1
48
107
M75.0
ICD-10 Finland
Adhesive capsulitis of shoulder
3.1
9.0
51
118
T84.0
ICD-10 Finland
Mechanical complication of internal joint prosthesis
3.1
9.0
51
118
L04
ICPC
Chest symptom/complaint
3.1
9.0
51
118
D10
ICPC
Vomiting
2.4
9.0
77
230
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
3.0
9.0
53
127
M09AX01
ATC
hyaluronic acid; parenteral
2.3
9.0
87
276
U01
ICPC
Dysuria/painful urination
4.2
9.0
35
60
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
1.7
9.0
215
947
J01CA08
ATC
pivmecillinam; oral
1.5
9.0
305
1467
AN2
HP
Balloon angioplasty, including several vessels
3.9
9.0
37
67
D01AE16
ATC
amorolfine; topical
1.9
9.0
135
513
H02AB09
ATC
hydrocortisone; systemic
5.0
9.0
29
41
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
3.2
9.0
47
104
A02BA02
ATC
ranitidine; systemic
1.5
9.0
397
2021
Y06
ICPC
Prostate symptom/complaint
4.2
9.0
34
57
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.2
9.0
48
108
N30
ICD-10 Finland
Cystitis
3.7
8.9
40
78
S52.5
ICD-10 Finland
Fracture of lower end of radius
2.1
8.9
105
364
E29.1
ICD-10 Finland
Testicular hypofunction
3.6
8.9
41
82
XQ802
NOMESCO Finland
Epicutan test
6.3
8.9
24
27
EBA10
NOMESCO Finland
Surgical removal of tooth
1.7
8.9
206
901
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
4.1
8.9
35
61
CS494
NOMESCO Finland
Other visual field testing
8.3
8.9
20
17
K08.3
ICD-10 Finland
Retained dental root
2.2
8.8
88
283
L75
ICPC
Fracture: femur
5.9
8.8
25
30
-54
ICPC
Repair/fix-suture/cast/prosth device
4.2
8.8
34
58
F41.8
ICD-10 Finland
Other specified anxiety disorders
4.2
8.8
34
58
177
Kela drug reimbursment
Insulin glargine 300 U / ml
4.9
8.8
29
42
C02AC05
ATC
moxonidine; oral
3.1
8.8
49
112
A08
ICPC
Swelling
3.9
8.8
36
65
H36.00
ICD-10 Finland
Diabetic background retinopathy
5.3
8.8
27
36
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
5.1
8.8
28
39
S00.0
ICD-10 Finland
Superficial injury of scalp
3.3
8.8
45
98
P18
ICPC
Medication abuse
9.0
8.8
19
15
I49.3
ICD-10 Finland
Ventricular premature depolarization
2.6
8.7
63
172
M01AX01
ATC
nabumetone; oral
2.6
8.7
63
172
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
3.8
8.7
37
69
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
3.4
8.7
43
91
D18
ICPC
Change in faeces/bowel movements
7.4
8.7
21
20
R83
ICPC
Respiratory infection other
1.5
8.7
325
1596
W22
ICD-10 Finland
Striking against or struck by other object(s)
1.9
8.7
131
500
I25.2
ICD-10 Finland
Old myocardial infarction
1.6
8.7
218
973
G04BD11
ATC
fesoterodine; oral
4.5
8.7
31
49
N18.8
ICD-10 Finland
Other chronic renal failure
3.2
8.7
45
99
FPE30
NOMESCO Finland
Replacement of transvenous cardiac pacemaker pulse generator
3.7
8.7
38
73
S22
ICPC
Nail symptom/complaint
3.1
8.7
49
114
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.7
8.7
58
151
C01CA24
ATC
epinephrine; parenteral
2.8
8.7
55
139
ZA1.0
ICD-10 Finland
Shoulder region
4.6
8.6
30
46
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
2.4
8.6
73
215
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
5.7
8.6
25
31
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.8
8.6
29
43
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.9
8.6
53
130
R07.2
ICD-10 Finland
Precordial pain
5.0
8.6
28
40
P06
ICPC
Sleep disturbance
2.1
8.6
100
345
SGC00
NOMESCO Finland
Local medication of root channels of tooth
1.8
8.6
162
665
Y94.8
ICD-10 Finland
Other leisure activity accident
3.5
8.6
40
81
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.4
8.6
495
2644
4148X
ICD-9 Finland
Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]
0.3
8.6
14
369
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.1
8.5
48
111
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.7
8.5
58
153
R52.0
ICD-10 Finland
Acute pain
3.4
8.5
42
89
SAB01
NOMESCO Finland
Restricted oral and dental health check by dental hygienist or dental assistant
2.2
8.5
90
297
WYA20
NOMESCO Finland
Home visit
3.6
8.5
39
78
R04.0
ICD-10 Finland
Epistaxis
2.0
8.5
108
387
SGA01
NOMESCO Finland
Tooth opening as first aid
1.6
8.5
262
1231
UJH02
NOMESCO Finland
Anoscopy
3.1
8.5
48
112
S01ED51
ATC
timolol, combinations; ophthalmic
1.9
8.5
127
483
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.8
8.4
138
542
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
2.3
8.4
80
252
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
3.3
8.4
42
90
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
1.7
8.4
162
671
SPAT1139
SPAT
Nutrition survey
3.5
8.4
39
79
I35.0
ICD-10 Finland
Aortic (valve) stenosis
2.0
8.4
109
394
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
2.4
8.4
72
216
ZYC01
NOMESCO Finland
Remote contact by phone
3.2
8.4
44
98
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.0
8.3
113
415
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
10.0
8.3
17
12
U04
ICPC
Incontinence urine
3.8
8.3
35
65
K08.80
ICD-10 Finland
Toothache NOS
2.2
8.3
82
263
R20.0
ICD-10 Finland
Anaesthesia of skin
11.3
8.3
16
10
S51.0
ICD-10 Finland
Open wound of elbow
4.7
8.3
28
42
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.9
8.2
127
487
Z51.6
ICD-10 Finland
Desensitization to allergens
5.4
8.2
25
33
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
0.5
8.2
50
751
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
4.2
8.2
31
52
C10AA04
ATC
fluvastatin; oral
2.0
8.2
112
413
SPAT1101
SPAT
Orthostatic test
3.0
8.2
47
111
I20.90
ICD-10 Finland
Angina pectoris, unspecified
2.1
8.2
95
328
TK820
NOMESCO Finland
Peritoneal dialysis
38.9
8.2
11
*
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
38.9
8.2
11
*
WX722
NOMESCO Finland
PEEP
2.4
8.2
68
201
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
+∞
8.2
9
*
L21.9
ICD-10 Finland
Seborrhoeic dermatitis, unspecified
4.1
8.1
32
56
L04AX01
ATC
azathioprine; systemic
2.5
8.1
64
182
V03AE02
ATC
sevelamer; oral
18.4
8.1
13
5
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
18.4
8.1
13
5
AA1XD
NOMESCO Finland
Other special CT of head and brain
18.4
8.1
13
5
B23.1
ICD-10 Finland
HIV disease resulting in (persistent) generalized lymphadenopathy
18.4
8.1
13
5
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.8
8.1
51
128
L72.1
ICD-10 Finland
Trichilemmal cyst
2.4
8.1
71
216
SPAT1058
SPAT
PEF monitoring instruction
2.7
8.1
55
145
ZX112
NOMESCO Finland
Subcutaneous
5.8
8.1
23
28
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
5.8
8.1
23
28
FPE00
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with ventricular electrode
2.6
8.1
61
170
J05AB11
ATC
valaciclovir; oral
1.9
8.1
126
487
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
4.2
8.1
31
53
K02.0
ICD-10 Finland
Caries limited to enamel
1.7
8.1
156
647
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
5.0
8.1
26
37
M62.6
ICD-10 Finland
Muscle strain
2.9
8.0
48
117
PD5AD
NOMESCO Finland
CT of aorta
9.3
8.0
17
13
R41.0
ICD-10 Finland
Disorientation, unspecified
2.3
8.0
75
235
U08
ICPC
Urinary retention
6.5
8.0
21
23
-44
ICPC
Preventive immunization/medic
2.2
8.0
82
268
N42.9
ICD-10 Finland
Disorder of prostate, unspecified
3.5
8.0
37
75
A10AA01
ATC
NA
2.6
8.0
60
167
Z96.6
ICD-10 Finland
Presence of orthopaedic joint implants
4.5
7.9
28
44
I50.0
ICD-10 Finland
Congestive heart failure
1.6
7.9
240
1122
R30.0
ICD-10 Finland
Dysuria
3.1
7.9
44
100
S01AX11
ATC
[U] ofloxacin; ophthalmic
1.9
7.9
123
475
R01AD01
ATC
beclometasone; nasal
1.6
7.9
212
964
F32.1
ICD-10 Finland
Moderate depressive episode
2.5
7.9
63
181
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.4
7.9
525
2868
N19
ICD-10 Finland
Unspecified kidney failure
2.4
7.9
69
209
F40.1
ICD-10 Finland
Social phobias
3.3
7.9
40
87
R00.0
ICD-10 Finland
Tachycardia, unspecified
3.1
7.9
44
101
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
3.1
7.9
44
101
Z97.2
ICD-10 Finland
Presence of dental prosthetic device (complete)(partial)
4.9
7.9
26
38
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
4.9
7.9
26
38
XA800
NOMESCO Finland
Neuropsychological investigation
3.0
7.9
45
106
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
1.9
7.9
121
466
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
5.3
7.9
24
32
R5599
NOMESCO Finland
Other rehabilitation service
5.1
7.9
25
35
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.1
7.9
42
95
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
8.0
7.8
18
16
SFA00
NOMESCO Finland
Small filling
1.8
7.8
147
605
A02BC04
ATC
rabeprazole; oral
2.2
7.8
83
276
SPAT1265
SPAT
Breathalyser
4.0
7.8
31
55
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.3
7.8
71
220
L05
ICPC
Flank/axilla symptom/complaint
2.7
7.8
52
135
4289X
ICD-9 Finland
Heart failure, unspecified
0.2
7.7
7
258
F39
ICD-10 Finland
Unspecified mood [affective] disorder
4.7
7.7
26
39
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.5
7.7
269
1302
R78
ICPC
Acute bronchitis/bronchiolitis
4.9
7.7
25
36
SPAT1279
SPAT
Preparation of immediate hospitalisation
5.2
7.7
24
33
G72.8
ICD-10 Finland
Other specified myopathies
3.3
7.7
39
85
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.4
7.7
65
194
H81.3
ICD-10 Finland
Other peripheral vertigo
4.2
7.7
29
49
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
9.4
7.7
16
12
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
9.4
7.7
16
12
EBA15
NOMESCO Finland
Extraction of large number of teeth
2.9
7.7
46
113
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
2.4
7.6
67
203
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.5
7.6
61
175
SGB10
NOMESCO Finland
Fiiling of rooth of tooth with one root channel
1.8
7.6
145
597
B02AA02
ATC
tranexamic acid; systemic
1.8
7.6
131
523
N05AF03
ATC
chlorprothixene; systemic
3.0
7.6
44
105
N18.0
ICD-10 Finland
End-stage renal disease
3.6
7.6
34
67
A63
ICPC
General and Unspecified, Follow-up encounter unspecified
12.4
7.6
14
8
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
12.4
7.6
14
8
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
3.3
7.6
38
82
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
7.6
560
3110
J01DC02
ATC
cefuroxime; systemic
2.3
7.6
69
212
K92.1
ICD-10 Finland
Melaena
1.9
7.6
105
390
R04
ICPC
Breathing problem other
3.5
7.6
35
71
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.6
7.6
55
151
Z71.9
ICD-10 Finland
Counselling, unspecified
2.5
7.6
58
164
R25.2
ICD-10 Finland
Cramp and spasm
4.6
7.6
26
40
JAB30
NOMESCO Finland
Repair of inguinal hernia using prosthetic material
1.6
7.5
182
806
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
4.1
7.5
29
50
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
3.7
7.5
33
64
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
5.6
7.5
22
28
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
2.4
7.5
66
200
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.9
7.5
108
406
H40.0
ICD-10 Finland
Glaucoma suspect
2.3
7.5
69
215
I84.1
ICD-10 Finland
Internal hemorrhoids with other complications
3.3
7.5
38
83
K99
ICPC
Cardiovascular disease other
4.2
7.5
28
47
L11
ICPC
Wrist symptom/complaint
2.4
7.5
61
179
L02BB03
ATC
bicalutamide; oral
2.2
7.5
79
263
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
2.6
7.5
52
140
D02
ICPC
Abdominal pain epigastric
3.1
7.5
40
91
R4120
NOMESCO Finland
Occupational therapy
2.4
7.5
64
193
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.1
7.4
87
301
R06.4
ICD-10 Finland
Hyperventilation
4.4
7.4
27
44
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
3.4
7.4
36
76
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.5
7.4
285
1408
H3603, E103
ICD-10 Finland
NA
6.2
7.4
20
23
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
8.7
7.4
16
13
G72.9
ICD-10 Finland
Myopathy, unspecified
8.7
7.4
16
13
F12.1
ICD-10 Finland
Mental and behavioural disorders due to use of cannabinoids, harmful use
8.7
7.4
16
13
R41.3
ICD-10 Finland
Other amnesia
3.1
7.4
41
94
E66.00
ICD-10 Finland
Metabolic syndrome
2.6
7.3
53
144
PA6AD
NOMESCO Finland
CT of neck arteries
17.0
7.3
12
5
K28
ICPC
Limited function/disability (K)
4.9
7.3
24
35
RJ411
NOMESCO Finland
NA
35.3
7.3
10
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
35.3
7.3
10
*
5BA08
NOMESCO Finland
NA
35.3
7.3
10
*
N03AF01
ATC
carbamazepine; oral, rectal
1.9
7.3
107
405
L09
ICPC
Arm symptom/complaint
2.9
7.3
43
104
F10.01
ICD-10 Finland
Alcohol-related acute intoxication with permanent or other somatic damage
9.7
7.3
15
11
K85.0
ICD-10 Finland
Idiopathic acute pancreatitis
9.7
7.3
15
11
L84
ICD-10 Finland
Corns and callosities
3.6
7.3
33
66
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.6
7.3
51
138
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.6
7.3
51
138
I20.09
ICD-10 Finland
Unstable angina
1.8
7.3
121
478
Y94.0
ICD-10 Finland
Accident at home
3.7
7.3
31
59
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
3.7
7.3
31
59
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
13.1
7.3
13
7
F11.24
ICD-10 Finland
Addiction-induced dependence caused by opiates active addiction
13.1
7.3
13
7
X78
ICD-10 Finland
Intentional self-harm by sharp object
11.0
7.3
14
9
Z49.2
ICD-10 Finland
Other dialysis
11.0
7.3
14
9
XG466
NOMESCO Finland
Sleep oxymetry
2.9
7.3
43
105
N28
ICPC
Limited function/disability (N)
6.4
7.2
19
21
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
5.9
7.2
20
24
K86
ICPC
Hypertension uncomplicated
2.2
7.2
72
234
K05.30
ICD-10 Finland
Periodontitis complex
1.8
7.2
113
439
XCD20
NOMESCO Finland
Photoangiography of eye
3.5
7.2
33
67
J01CF05
ATC
flucloxacillin; systemic
2.8
7.2
46
118
101
Kela drug reimbursment
Anterior pituitary hypofunction
4.9
7.2
23
33
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.5
7.2
217
1018
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.4
7.1
34
71
F99
ICD-10 Finland
Mental disorder, not otherwise specified
3.7
7.1
31
60
G54.0
ICD-10 Finland
Brachial plexus disorders
3.7
7.1
31
60
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
3.9
7.1
29
53
G04BD07
ATC
tolterodine; oral
1.9
7.1
101
378
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.1
7.1
78
263
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
6.7
7.1
18
19
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
4.3
7.1
26
43
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
7.1
656
3762
P05
ICPC
Senility, feeling/behaving old
8.1
7.1
16
14
I50
ICD-10 Finland
Heart failure
2.5
7.1
55
157
M13.9
ICD-10 Finland
Arthritis, unspecified
2.1
7.1
76
255
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.7
7.1
30
57
NH1AD
NOMESCO Finland
Ankle and foot CT
4.0
7.1
28
50
L81
ICPC
Injury musculoskeletal NOS
4.0
7.1
28
50
SDA02
NOMESCO Finland
Parodonthologic therapy
1.4
7.1
347
1799
S01EE01
ATC
latanoprost; ophthalmic
1.9
7.1
95
350
C09AA04
ATC
perindopril; oral
2.0
7.0
86
303
R63.4
ICD-10 Finland
Abnormal weight loss
3.4
7.0
34
72
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.6
7.0
164
720
C01BC04
ATC
flecainide; systemic
3.6
7.0
31
61
S82.6
ICD-10 Finland
Fracture of lateral malleolus
2.1
7.0
80
276
M24.2
ICD-10 Finland
Disorder of ligament
4.1
7.0
27
47
K50.0
ICD-10 Finland
Crohn disease of small intestine
4.1
7.0
27
47
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
8.9
7.0
15
12
S16
ICPC
Bruise/contusion
3.8
7.0
29
54
S01
ICPC
Pain/tenderness of skin
3.2
7.0
36
80
SPF10
NOMESCO Finland
Demanding repatation of teeth prosthesis
5.7
7.0
20
25
SPAT1099
SPAT
Measurement of blood pressure with Doppler ultrasound device
4.8
7.0
23
34
I42.0
ICD-10 Finland
Dilated cardiomyopathy
2.8
7.0
44
111
F32.8
ICD-10 Finland
Other depressive episodes
5.0
7.0
22
31
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
5.3
7.0
21
28
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
7.1
7.0
17
17
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.6
7.0
51
141
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
2.3
7.0
65
204
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
2.0
6.9
84
297
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.7
6.9
30
58
M23.8
ICD-10 Finland
Other internal derangements of knee
2.6
6.9
49
134
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.5
6.9
230
1100
C03DA01
ATC
spironolactone; oral
1.6
6.9
177
796
A10BB01
ATC
glibenclamide; oral
0.6
6.9
95
1124
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.6
6.9
192
882
N18
ICPC
Paralysis/weakness
4.3
6.9
25
41
KH1AD
NOMESCO Finland
CT of urinary organs
3.0
6.9
39
92
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.7
6.9
150
647
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
3.7
6.9
29
55
F41.0
ICD-10 Finland
Panic disorder [episodic paroxysmal anxiety]
4.0
6.9
27
48
J45
ICD-10 Finland
Asthma
2.0
6.9
83
293
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.9
6.8
93
343
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
2.0
6.8
91
333
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
2.2
6.8
65
207
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.1
6.8
72
240
N03AF02
ATC
oxcarbazepine; oral
2.6
6.8
50
138
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
3.3
6.8
34
74
UDC00
NOMESCO Finland
Ear microscopy
2.1
6.8
74
250
Z75.1
ICD-10 Finland
Person awaiting admission to adequate facility elsewhere
4.9
6.8
22
32
A27
ICPC
Fear of other disease NOS
3.2
6.8
35
78
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
3.8
6.8
28
52
K59.0
ICD-10 Finland
Constipation
1.9
6.8
102
391
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
23.6
6.8
10
*
B24
ICD-10 Finland
Unspecified human immunodeficiency virus [HIV] disease
23.6
6.8
10
*
Z12.5
ICD-10 Finland
Special screening examination for neoplasm of prostate
23.6
6.8
10
*
Y90.8
ICD-10 Finland
Blood alcohol level of 240 mg/100 ml or more
23.6
6.8
10
*
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
23.6
6.8
10
*
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
0.4
6.8
21
409
J02AC02
ATC
itraconazole; systemic
1.6
6.8
186
853
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
3.4
6.7
32
67
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
2.2
6.7
66
212
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.5
6.7
50
140
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
3.9
6.7
27
49
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.5
6.7
272
1358
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
2.2
6.7
66
213
A34
ICPC
General and Unspecified, Blood test
4.4
6.7
24
39
SPAT1146
SPAT
Puncture of abscess or incision of skin
4.4
6.7
24
39
M75.8
ICD-10 Finland
Other shoulder lesions
3.6
6.7
30
60
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
2.5
6.7
53
154
A04AA01
ATC
ondansetron; systemic, rectal
2.9
6.7
40
99
A50
ICPC
General and Unspecified, Medication/prescr/renewal
2.8
6.7
43
111
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
2.5
6.7
52
148
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
2.4
6.7
58
176
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
4.5
6.7
23
36
R95
ICPC
Chron obstructive pulmonary disease
4.5
6.7
23
36
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
2.2
6.7
68
223
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
3.4
6.7
31
64
X57
ICD-10 Finland
Unspecified privation
3.1
6.7
37
85
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.8
6.6
107
421
M01AB08
ATC
etodolac; oral
2.2
6.6
68
224
N06AA09
ATC
amitriptyline; systemic
1.8
6.6
119
484
Z04
ICD-10 Finland
Examination and observation for other reasons
5.6
6.6
19
24
R00.1
ICD-10 Finland
Bradycardia, unspecified
2.3
6.6
60
185
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.1
6.6
73
249
S09
ICPC
Infected finger/toe
3.6
6.6
29
57
G30
ICD-10 Finland
Alzheimer disease
3.6
6.6
29
57
N07BA03
ATC
varenicline; oral
2.0
6.6
79
278
E000002
ATC
NA
1.6
6.6
160
711
F40.01
ICD-10 Finland
Agoraphobia with concomitant panic disorder
15.6
6.6
11
5
M16.0
ICD-10 Finland
Primary coxarthrosis, bilateral
2.2
6.6
66
216
K07.60
ICD-10 Finland
Snapping jaw
3.1
6.6
35
80
K04.0
ICD-10 Finland
Pulpitis
1.6
6.6
164
732
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
10.2
6.6
13
9
K29
ICPC
Cardiovascular sympt/complt other
3.4
6.5
31
65
M46.4
ICD-10 Finland
Discitis, unspecified
12.1
6.5
12
7
R43
ICPC
Respiratory, Other diagnostic procedure
12.1
6.5
12
7
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.4
6.5
54
159
NGF35
NOMESCO Finland
Plastic operation of joint cartilage of knee
2.8
6.5
41
103
S20.2
ICD-10 Finland
Contusion of thorax
2.1
6.5
76
264
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.6
6.5
182
838
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
31.8
6.5
9
*
S02.51
ICD-10 Finland
Fracture of tooth, open
1.9
6.5
94
354
AN3
HP
Balloon angioplasty and metallic stent
2.6
6.5
46
126
L18
ICPC
Muscle pain
3.2
6.5
33
73
R08
ICPC
Nose symptom/complaint other
3.2
6.5
33
73
R49.08
ICD-10 Finland
Other specified dysphonia
6.3
6.5
17
19
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
3.5
6.5
29
58
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
2.3
6.5
60
189
R39.1
ICD-10 Finland
Other difficulties with micturition
2.9
6.5
39
97
K57.9
ICD-10 Finland
Diverticular disease of intestine, part unspecified, without perforation or abscess
2.9
6.5
39
97
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.8
6.5
41
104
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
2.6
6.5
48
134
W10
ICD-10 Finland
Fall on and from stairs and steps
2.2
6.5
65
213
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
4.0
6.5
25
44
B05DA
ATC
Isotonic solutions
7.6
6.5
15
14
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
5.8
6.5
18
22
F31
ICD-10 Finland
Bipolar affective disorder
5.8
6.5
18
22
P27
ICPC
Fear of mental disorder
5.8
6.5
18
22
ND1BA
NOMESCO Finland
Wrist extensive X-ray examination
4.8
6.4
21
31
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
4.8
6.4
21
31
S12
ICPC
Insect bite/sting
2.6
6.4
45
122
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
5.1
6.4
20
28
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.8
6.4
103
404
M65.3
ICD-10 Finland
Trigger finger
3.0
6.4
37
89
I49.4
ICD-10 Finland
Other and unspecified premature depolarization
3.2
6.4
33
74
ND1AA
NOMESCO Finland
Wrist X-ray examination
2.4
6.4
51
149
N06AX03
ATC
mianserin; oral
2.0
6.4
77
271
S01.9
ICD-10 Finland
Open wound of head, part unspecified
2.9
6.4
38
94
M65.9
ICD-10 Finland
Synovitis and tenosynovitis, unspecified
3.5
6.4
29
59
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
3.5
6.4
29
59
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
2.8
6.4
41
106
S15
ICPC
Foreign body in skin
2.8
6.4
41
106
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
4.3
6.4
23
38
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.5
6.4
218
1053
F60.2
ICD-10 Finland
Dissocial personality disorder
6.7
6.3
16
17
TKC50
NOMESCO Finland
Training of urinary bladder
56.6
6.3
8
*
ZXH01
NOMESCO Finland
Procedure performed within operation theatre
56.6
6.3
8
*
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
8.3
6.3
14
12
E87.5
ICD-10 Finland
Hyperkalaemia
2.8
6.3
40
101
NF3AA
NOMESCO Finland
Femur X-ray examination
3.4
6.3
30
63
FM1LE
NOMESCO Finland
Combined ultrasound and EKG examination of heart with tolerance test
+∞
6.3
7
*
EB1MA
NOMESCO Finland
Cephalometry with X-ray
3.9
6.3
25
45
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
2.0
6.3
81
293
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.5
6.3
48
137
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
4.5
6.3
22
35
RS222
NOMESCO Finland
NA
4.5
6.3
22
35
4273A
ICD-9 Finland
Cardiac dysrhythmias, Atrial fibrillation and flutter
0.5
6.3
42
610
S80.0
ICD-10 Finland
Contusion of knee
2.1
6.3
72
248
I42.9
ICD-10 Finland
Cardiomyopathy, unspecified
4.1
6.3
24
42
K03.00
ICD-10 Finland
Approximal wear
2.3
6.3
55
167
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.8
6.3
26
49
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
1.9
6.3
92
349
M77.0
ICD-10 Finland
Medial epicondylitis
3.4
6.3
29
60
L04AA01
ATC
[U] ciclosporin; systemic
4.9
6.3
20
29
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.2
6.2
19
26
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
5.2
6.2
19
26
104
Kela drug reimbursment
Thyroid insufficiency
2.1
6.2
72
250
103
Kela drug reimbursment
Diabetes, insulin-treated
1.3
6.2
456
2522
SPAT1307
SPAT
Psychosocial counselling and guidance
2.3
6.2
58
183
N05CD07
ATC
temazepam; oral
1.4
6.2
371
1989
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
3.3
6.2
30
64
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
3.3
6.2
30
64
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
2.7
6.2
43
115
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
2.4
6.2
50
147
N62
ICD-10 Finland
Hypertrophy of breast
4.2
6.2
23
39
B80
ICPC
Iron deficiency anaemia
7.1
6.2
15
15
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
7.1
6.2
15
15
RD210
NOMESCO Finland
NA
7.1
6.2
15
15
P28
ICPC
Limited function/disability (P)
7.1
6.2
15
15
H11.3
ICD-10 Finland
Conjunctival haemorrhage
3.2
6.2
32
72
D09
ICPC
Nausea
3.2
6.2
32
72
ZXD35
NOMESCO Finland
Usual procedure
2.2
6.2
58
184
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
10.6
6.2
12
8
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
2.6
6.2
46
128
N20.9
ICD-10 Finland
Urinary calculus, unspecified
3.1
6.2
33
76
C44.30
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face without histology
3.1
6.2
33
76
S90.3
ICD-10 Finland
Contusion of other and unspecified parts of foot
2.9
6.2
37
92
R99
ICD-10 Finland
Other ill-defined and unspecified causes of mortality
2.9
6.2
37
92
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.6
6.2
43
116
R03AC03
ATC
terbutaline; inhalant
1.5
6.2
190
895
-62
ICPC
Administrative procedure
3.5
6.2
28
57
Z02.4
ICD-10 Finland
Examination for driving licence
1.5
6.2
235
1159
AP1
HP
Catheterization of the left side of the heart
4.3
6.2
22
36
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
4.3
6.2
22
36
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
2.8
6.2
39
99
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
2.2
6.2
58
185
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
2.9
6.2
36
88
M19.1
ICD-10 Finland
Post-traumatic arthrosis of other joints
3.4
6.1
29
61
I21.41
ICD-10 Finland
Acute subendocardial infarction stenosed coronary artery
2.3
6.1
55
171
R06AX13
ATC
loratadine; oral
1.5
6.1
185
867
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.6
6.1
147
650
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.5
6.1
229
1128
L29.9
ICD-10 Finland
Pruritus, unspecified
3.5
6.1
27
54
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
4.7
6.1
20
30
N45.0
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis with abscess
5.7
6.1
17
21
T99
ICPC
Endocr/metab/nutrit disease other
5.7
6.1
17
21
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
5.7
6.1
17
21
H81.0
ICD-10 Finland
Ménière disease
5.7
6.1
17
21
K62.6
ICD-10 Finland
Ulcer of anus and rectum
7.6
6.1
14
13
F15.2
ICD-10 Finland
Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome
7.6
6.1
14
13
J33.0
ICD-10 Finland
Polyp of nasal cavity
2.6
6.1
43
118
137
Kela drug reimbursment
Uraemia requiring dialysis
5.0
6.1
19
27
Y07
ICD-10 Finland
Other maltreatment
4.1
6.1
23
40
FMD00
NOMESCO Finland
Replacement of aortic valve using mechanical prosthesis
5.3
6.1
18
24
Z43.5
ICD-10 Finland
Attention to cystostomy
5.3
6.1
18
24
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
5.3
6.1
18
24
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
3.4
6.1
28
58
WW500
NOMESCO Finland
Blood transfusion
2.7
6.0
40
106
N06AA06
ATC
trimipramine; systemic
3.0
6.0
34
80
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
2.5
6.0
46
132
R10.0
ICD-10 Finland
Acute abdomen
2.6
6.0
43
119
ACC53
NOMESCO Finland
Release of ulnar nerve
4.2
6.0
22
37
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
7052
22035
1.75
322.40
2.0
1.6
%
1.5
1.4
26.54
6253
19595
(3033658) Prothrombin time (PT) actual/Normal
11746
41943
1.58
322.19
4.7
3.4
%
90.3
90.2
0.21
11408
40950
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
39688
183116
1.64
322.05
5.0
4.1
mmol/l
2.7
2.8
114.69
36599
169668
(3005322) IgE [Units/volume] in Serum or Plasma
3491
8579
2.17
318.33
1.4
1.2
u/ml
256.6
256.0
0.01
3250
7927
(3028026) IgM [Mass/volume] in Serum or Plasma
3317
7990
2.21
317.23
1.9
1.9
g/l
1.3
1.3
0.12
2997
7308
(3000850) Epithelial cells [#/volume] in Urine
9568
32754
1.62
310.61
3.0
2.3
e6/l
5.2
6.0
5.82
8667
28264
(3017354) Segmented neutrophils/100 leukocytes in Blood
876
899
5.06
310.43
3.2
2.9
%
59.3
58.8
0.14
515
612
(3000494) Fungus identified in Specimen by Culture
5699
16902
1.82
308.28
1.6
1.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
4796
11906
2.18
307.65
9.8
5.9
mmol/l
9.7
9.6
0.58
4538
11309
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
5026
13858
1.96
307.65
2.8
2.3
u/l
34.6
45.8
2.54
4275
11946
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
7863
24211
1.79
307.65
1.3
1.2
u/ml
13.0
11.7
0.47
2894
9864
(3020682) Albumin/Creatinine [Ratio] in Urine
13180
44612
1.71
307.65
4.5
3.7
mg/mmol
10.9
8.6
4.26
8299
28177
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
12320
37039
1.95
307.65
2.7
2.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
4967
9796
2.78
307.65
3.7
2.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
8620
26091
1.84
307.65
3.0
2.5
e6/l
1.0
1.3
1.92
5876
12961
(3007164) IgA [Mass/volume] in Serum or Plasma
10165
29747
1.95
307.65
1.6
1.4
g/l
2.3
2.4
1.35
6194
18839
(3048689) Calprotectin [Mass/mass] in Stool
6897
18101
2.11
307.65
2.4
2.5
ug/g
122.5
138.9
2.97
5364
14421
(3042936) Bacteria identified in Isolate by Culture
7119
20551
1.91
307.65
2.3
1.8
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
11466
32845
2.04
307.65
2.1
1.6
mg/l
1.1
1.2
1.76
8467
25099
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
34200
124970
2.40
307.65
8.8
6.4
u/l
77.9
77.9
0.05
32401
116792
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
21353
65899
2.19
307.65
7.0
5.3
mmol/l
1.2
1.2
9.86
19244
59666
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
4135
9507
2.34
307.65
2.4
2.3
au/ml
23.7
22.9
0.15
220
722
(4146454)
1310
582
11.82
307.65
3.1
1.9
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
4903
12461
2.13
307.65
6.9
7.0
mmol/l
1.4
1.3
0.43
4742
12054
(3009508) Creatinine [Moles/volume] in Urine
14250
46296
1.82
307.65
3.9
2.9
mmol/l
7.8
8.1
8.80
11648
39059
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
4094
8870
2.49
307.65
4.7
3.5
ng/l
91.8
88.1
1.32
3583
7610
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
19837
61577
2.11
307.65
2.5
2.0
nmol/l
4691.5
75.5
0.50
17765
55721
(3030467) Casts [#/volume] in Urine by Automated count
12842
44442
1.66
307.65
3.7
2.7
e6/l
0.3
0.5
6.03
10435
31489
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
14126
36863
2.36
307.65
3.4
2.7
ng/l
1426.6
1437.6
0.08
11833
31182
(3013826) Glucose [Moles/volume] in Serum or Plasma
27527
92698
2.22
307.65
5.5
4.1
mmol/l
6.7
6.6
5.45
25931
85073
(3024731) MCV [Entitic volume]
44761
212082
2.22
307.65
26.4
15.3
fl
90.8
90.5
38.51
44180
208600
(3011397) Hemoglobin [Presence] in Urine by Test strip
10540
36259
1.63
307.65
4.0
2.9
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
4996
13076
2.07
307.65
5.0
3.3
mmol/l
2.0
1.8
4.38
4020
10807
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
7173
18962
2.10
307.65
3.0
2.2
%
22.9
23.4
2.24
6335
16208
(3021447) Carbon dioxide [Partial pressure] in Venous blood
4951
13133
2.04
307.65
5.0
3.4
kpa
5.9
5.8
4.47
4808
12779
(3021960) Folate [Moles/volume] in Serum or Plasma
11087
32019
2.01
307.65
1.6
1.5
nmol/l
20.1
19.9
0.48
9458
27586
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
6129
15643
2.15
307.65
4.8
3.9
u/l
237.6
245.4
2.93
5726
14865
(3014051) Protein [Presence] in Urine by Test strip
2185
2336
4.97
307.65
2.4
1.7
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
44761
212117
2.21
307.65
26.5
15.4
e12/l
4.5
4.6
106.29
43874
204298
(3019225) pH of Specimen
6764
10789
3.57
307.65
4.9
3.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
4919
10737
2.50
307.65
3.4
2.2
ml/min/173m2
65.5
69.4
5.38
1663
4310
(3015377) Calcium [Moles/volume] in Serum or Plasma
14909
50871
1.73
307.65
3.2
3.4
mmol/l
2.3
2.4
3.42
12521
45239
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
43207
197030
2.24
307.65
12.5
8.1
u/l
27.5
27.0
2.34
41747
189655
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
2434
4311
2.99
307.65
2.4
2.2
ug/l
433.4
612.6
1.30
2240
4052
(3023103) Potassium [Moles/volume] in Serum or Plasma
42431
182878
2.63
307.65
20.0
12.3
mmol/l
4.0
4.0
5.93
41337
176775
(3022621) pH of Urine by Test strip
3965
9720
2.19
307.65
3.0
2.6
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
42379
182125
2.65
307.65
19.8
12.2
mmol/l
139.6
139.7
7.88
41382
176432
(3007853) Bacteria identified in Skin by Aerobe culture
6197
16799
2.02
307.65
2.0
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
4474
10683
2.26
307.65
2.7
2.5
e9/l
71.3
68.6
4.14
3591
7578
(3020630) Protein [Mass/volume] in Serum or Plasma
4127
10562
2.10
307.65
2.6
2.3
g/l
66.7
66.6
0.61
3708
9683
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
11373
34333
1.91
307.65
1.3
1.2
u/ml
1.9
1.8
0.24
2756
9876
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
5446
15539
1.90
307.65
1.9
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
1057
1212
4.54
307.65
1.5
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
38113
171266
1.68
307.65
4.3
3.4
mmol/l
1.3
1.3
28.69
35028
158356
(3031040) Bacteria [#/volume] in Urine by Automated count
29254
108578
1.97
307.65
5.2
3.6
e6/l
1237.9
1222.4
0.01
190
2182
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
39243
179894
1.65
307.65
4.7
3.8
mmol/l
4.6
4.7
158.29
36318
168016
(42870588) Differential panel, method unspecified - Blood
17229
52656
2.05
307.65
7.0
5.3
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
7728
22215
1.93
307.65
2.5
1.9
s
30.0
29.9
0.25
7528
21592
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
1040
1160
4.67
307.65
1.5
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
3048
4602
3.55
307.65
2.2
1.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
1580
2240
3.70
307.65
4.1
2.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
38931
178533
1.62
307.65
4.7
3.7
mmol/l
1.4
1.4
49.63
35918
165866
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
15634
41549
2.38
307.65
2.4
1.9
u/l
215.7
229.2
0.50
14775
38757
(3006315) Basophils [#/volume] in Blood
24573
78726
2.23
307.65
7.0
5.1
e9/l
0.0
0.0
3.71
22060
66186
(3002582) Erythrocytes [#/volume] in Urine
13815
48692
1.64
307.65
3.8
2.8
e6/l
66.4
108.4
2.70
11449
35249
(3001604) Monocytes [#/volume] in Blood
24444
78443
2.22
307.65
7.0
5.1
e9/l
0.6
0.6
0.90
21972
65950
(3022217) INR in Platelet poor plasma by Coagulation assay
8784
14539
3.56
307.65
20.2
24.5
inr
1.3
1.4
1.37
1241
1783
(3024561) Albumin [Mass/volume] in Serum or Plasma
19648
65072
1.93
307.65
5.5
4.3
g/l
35.8
35.6
2.80
18221
60082
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
7754
15051
2.95
307.65
4.8
3.8
%
32.1
31.7
1.76
5217
10325
(3035941) MCH [Entitic mass]
44752
212060
2.21
307.65
26.3
15.3
pg
30.3
30.2
4.03
44177
208583
(3010813) Leukocytes [#/volume] in Blood
44781
212164
2.22
307.65
26.5
15.4
e9/l
6.9
6.7
31.89
43892
204329
(3012095) Magnesium [Moles/volume] in Serum or Plasma
8039
23315
1.92
307.65
4.0
3.1
mmol/l
0.8
0.8
1.67
7457
21742
(3025468) Yersinia sp identified in Specimen by Organism specific culture
1029
1153
4.65
307.65
1.5
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
13087
40154
1.92
307.65
4.6
4.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
3889
9309
2.24
307.65
1.8
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
21162
77937
1.70
307.65
4.3
3.7
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
15013
50935
1.74
307.65
2.8
2.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
12738
45330
1.60
307.65
4.9
3.6
ph
7.4
7.4
9.01
1684
10307
(3045414) Leukocytes [Presence] in Urine
3308
5328
3.34
307.65
2.1
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
5709
15376
2.02
307.65
2.8
2.4
%
1.8
1.7
7.91
4934
13662
(3007461) Platelets [#/volume] in Blood
44742
211795
2.22
307.65
26.5
15.4
e9/l
251.4
251.9
0.72
43938
204701
(3003458) Phosphate [Moles/volume] in Serum or Plasma
6943
17712
2.18
307.65
7.5
4.8
mmol/l
1.1
1.0
8.18
6446
16469
(3019198) Lymphocytes [#/volume] in Blood
25030
81871
2.18
307.65
7.0
5.1
e9/l
1.9
1.9
1.99
22645
70752
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
39426
168151
2.13
307.65
15.1
10.5
ml/min/173m2
84.2
84.5
1.98
34452
134149
(3013650) Neutrophils [#/volume] in Blood by Automated count
27454
92873
2.20
307.65
10.3
8.0
e9/l
4.1
4.2
2.92
24779
78951
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
6033
16751
1.97
307.65
3.4
2.4
umol/l
7.8
9.2
3.94
5302
14395
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
9702
27226
2.03
307.65
4.1
3.2
ng/l
366.1
591.0
5.63
7200
20501
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
8684
21881
2.26
307.65
2.0
1.6
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
4340
10155
2.31
307.65
2.9
2.5
g/l
10.5
10.8
4.62
4007
9198
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
15917
45636
2.18
307.65
3.0
2.3
u/l
56.3
59.6
6.82
14758
41910
(3012544) pH of Venous blood
5071
13620
2.01
307.65
5.0
3.4
ph
7.4
7.4
1.00
17
88
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
4218
7320
3.14
307.65
4.1
3.0
mmol/l
1.3
1.9
17.94
3116
5296
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
38952
171838
1.86
307.65
4.9
3.8
mmol/l
6.0
5.8
74.83
35624
157299
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
6889
15469
2.50
307.65
7.3
5.6
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
3284
4254
4.17
307.65
4.3
3.3
mmol/l
24.6
24.8
2.49
3026
3948
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
42152
181896
2.54
307.65
18.2
10.6
mg/l
22.0
24.8
48.15
34819
138332
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
7918
24452
1.79
307.65
3.2
2.6
e6/l
2.4
2.8
2.11
5188
11385
(40768804) Tissue Pathology biopsy report
17788
65715
1.61
307.65
2.2
1.9
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
1030
1155
4.65
307.65
1.5
1.3
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
23163
74451
2.15
307.65
7.1
5.2
%
2.9
2.8
2.41
21646
69207
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
23812
71717
2.39
307.65
8.1
5.5
mmol/l
1.2
1.2
1.72
21018
57728
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
4405
7590
3.17
307.65
4.1
3.1
kpa
5.1
5.1
0.08
4016
7097
(3036481) Cortisol [Moles/volume] in Serum or Plasma
5737
12063
2.63
307.65
2.4
2.2
nmol/l
365.8
381.2
5.79
5179
11237
(3017732) Neutrophils [#/volume] in Blood
4162
9955
2.25
307.65
2.9
2.5
e9/l
4.1
4.2
0.63
2987
8110
(3001122) Ferritin [Mass/volume] in Serum or Plasma
20643
72848
1.79
307.65
3.3
2.5
ug/l
131.8
121.5
2.07
19142
67694
(3012516) Albumin [Mass/volume] in Urine
12680
42147
1.74
307.65
3.8
3.0
mg/l
367.5
328.1
0.42
7936
26667
(40761511) CBC panel - Blood by Automated count
42717
194246
2.16
307.65
16.4
10.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
18218
55644
2.09
307.65
4.2
3.0
ng/l
93.3
61.0
0.55
12385
34795
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
12791
35693
2.14
307.65
2.5
2.0
mg/l
3.0
2.9
2.70
10803
30233
(3022313) Gas panel - Capillary blood
3474
4996
3.76
307.65
4.2
3.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
13281
38224
2.08
307.65
8.1
6.1
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
23720
78248
2.09
307.65
7.3
5.2
%
28.1
28.3
1.58
22120
72883
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
8354
25957
1.79
307.65
1.3
1.2
iu/ml
43.0
38.0
0.31
2407
8326
(3000963) Hemoglobin [Mass/volume] in Blood
44771
212217
2.21
307.65
26.6
15.4
g/l
135.3
137.0
110.11
44188
208800
(3037522) Nuclear Ab [Titer] in Serum
7515
19940
2.10
307.65
1.4
1.3
titre
540.8
533.2
0.11
1572
3590
(40768797) Stomach Pathology biopsy report
7086
17616
2.24
307.65
1.3
1.2
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
23463
76718
2.11
307.65
7.0
5.1
%
57.1
57.1
0.01
22000
71780
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
3696
7375
2.70
307.65
1.6
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
12843
44404
1.66
307.65
3.3
2.6
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
4964
13155
2.04
307.65
2.7
2.0
g/l
0.2
0.2
0.19
4583
12226
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
3806
7208
2.85
307.65
1.8
1.5
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
8356
22104
2.13
307.65
2.9
2.2
umol/l
13.3
13.5
1.33
7708
20420
(3013707) Erythrocyte sedimentation rate by Westergren method
32993
121084
2.27
307.65
4.8
3.3
mm/h
11.6
11.3
4.33
30569
111662
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
2785
4240
3.51
307.65
2.0
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
33382
131563
1.99
307.65
4.4
3.5
pmol/l
14.7
14.7
3.95
30559
119081
(3032080) INR in Blood by Coagulation assay
18183
61456
1.83
307.65
8.5
8.2
inr
1.2
1.2
0.42
4543
19832
(3018095) Leukocytes [#/volume] in Urine
15937
57570
1.63
307.65
4.2
3.1
e6/l
71.7
102.2
5.38
12161
38177
(3037121) Protein [Mass/volume] in Urine
2138
4114
2.74
307.65
3.2
3.4
g/l
0.4
0.3
1.05
878
2042
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
1029
1153
4.65
307.65
1.5
1.3
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
23238
74957
2.14
307.65
7.5
5.4
%
8.6
8.6
0.00
21795
70109
(3013115) Eosinophils [#/volume] in Blood
25334
81436
2.26
307.65
7.4
5.2
e9/l
0.2
0.2
0.02
22752
70121
(3022096) Basophils/100 leukocytes in Blood
22513
72134
2.13
307.65
7.2
5.3
%
0.7
0.7
3.57
21021
67159
(3004789) Transferrin [Mass/volume] in Serum or Plasma
7692
20382
2.11
307.65
2.9
2.2
g/l
2.3
2.3
0.16
7128
18671
(3024522) Salmonella sp identified in Specimen by Organism specific culture
1042
1176
4.62
307.65
1.5
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
12233
43758
1.58
307.65
3.6
2.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
15611
53584
1.73
307.65
3.7
2.7
u/l
35.4
34.0
0.44
14842
50604
(3026493) Urate [Moles/volume] in Serum or Plasma
12037
41990
1.63
307.65
3.0
2.3
umol/l
3676.1
5309.4
4.19
10463
36718
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
38794
161275
2.21
307.65
5.4
4.0
mu/l
2.1
2.2
0.39
35711
147762
(3037467) Urinalysis macro (dipstick) panel - Urine
30636
115821
1.98
307.65
5.1
3.5
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
4922
9797
2.75
307.65
2.5
2.0
ug/l
7.0
8.5
3.27
4116
8584
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
5507
15401
1.94
307.65
1.9
1.6
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
43082
195587
2.26
307.65
19.8
12.3
umol/l
79.1
76.2
42.01
43058
195466
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
24610
79030
2.22
307.65
6.8
5.5
umol/l
11.1
11.9
15.93
23275
74544
(3000330) Specific gravity of Urine by Test strip
3464
6697
2.78
307.65
3.5
3.1
—
—
—
0
0
(3013512) EKG study
14117
41084
2.08
307.65
4.5
3.3
—
—
—
0
0
(3009343) pH of Capillary blood
4368
7518
3.17
307.65
4.1
3.1
ph
7.4
7.4
0.21
270
1542
(3019309) Folate [Moles/volume] in Red Blood Cells
9375
24270
2.22
307.65
1.8
1.8
nmol/l
1093.3
1205.3
22.01
6953
18175
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
3814
8663
2.36
307.65
1.3
1.2
au/ml
42.7
48.9
0.71
126
423
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
19947
57689
2.32
307.65
2.1
1.7
pmol/l
97.3
95.0
7.46
10808
29927
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
37017
159984
1.81
307.65
6.5
4.6
mmol/mol
39.9
38.8
72.85
34171
148363
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
29879
122141
1.67
307.65
3.9
2.6
u/l
50.4
45.1
16.95
27998
114845
(3024354) Oxygen [Partial pressure] in Venous blood
4081
10839
2.01
304.59
4.2
2.8
kpa
4.7
4.6
3.36
3937
10502
(3017143) Hepatitis C virus Ab [Presence] in Serum
6461
19986
1.76
304.07
1.8
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
1118
1466
3.98
301.63
1.8
1.6
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2532
5562
2.41
296.85
2.1
1.9
u/l
39.4
39.0
0.34
2258
4935
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
2569
5719
2.37
292.68
1.8
1.6
g/l
1.5
1.5
0.13
2199
4826
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
1753
3206
2.87
291.10
1.4
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
3389
8550
2.11
288.57
2.4
2.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
1766
3270
2.83
287.00
1.5
1.4
ug/g
282.4
268.1
1.31
1002
1886
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
1455
2400
3.17
285.73
1.5
1.2
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
2537
5730
2.34
279.82
1.5
1.5
u/ml
11.1
13.4
0.37
68
149
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
1835
3548
2.71
275.94
1.4
1.5
iu/ml
10.0
13.3
0.41
30
84
(3014576) Chloride [Moles/volume] in Serum or Plasma
5910
18294
1.75
275.24
7.8
6.9
mmol/l
104.5
104.5
0.22
5835
17806
(3022145) Colonoscopy Study observation
5424
16373
1.79
274.86
1.3
1.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
3952
10786
1.96
272.20
3.1
2.6
ng/l
208.0
208.0
0.00
3605
9748
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
2090
4366
2.52
271.12
1.5
1.6
titre
289.5
283.0
0.03
62
185
(36660697) Celiac disease serology panel - Serum
4225
11914
1.90
264.35
1.2
1.1
—
—
—
0
0
(4010399)
3628
9741
1.98
261.10
1.5
1.4
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
5179
15680
1.78
258.81
7.6
7.2
kpa
5.1
5.1
0.69
4943
14912
(3027801) Oxygen [Partial pressure] in Arterial blood
5176
15669
1.78
258.76
7.6
7.2
kpa
12.3
12.7
5.29
4931
14896
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
1897
3933
2.53
249.47
1.9
1.7
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
1405
2485
2.95
246.42
1.3
1.2
u/ml
19.5
14.8
0.20
17
45
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
1772
3580
2.59
245.03
1.3
1.2
u/ml
34.0
36.5
0.13
109
230
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
3417
9207
1.97
242.82
3.4
3.5
pmol/l
4.5
4.6
1.63
2987
8334
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
28943
127984
1.40
239.53
3.4
3.0
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
5133
15837
1.74
239.33
7.6
7.2
mmol/l
1.0
0.9
1.28
3961
12543
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
2762
6926
2.11
237.31
5.3
3.6
mmol/l
24.1
24.2
0.17
2483
6231
(3004616) Nuclear Ab [Presence] in Serum
926
1269
3.79
236.01
1.3
1.2
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
2206
5074
2.29
232.74
2.1
1.8
ug/l
1.6
2.5
3.21
1905
4520
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
777
940
4.29
230.61
1.9
2.2
nmol/l
20.5
18.9
3.11
701
906
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
2899
7492
2.04
230.26
9.0
9.7
mmol/l
24.3
24.4
0.39
2710
7037
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
1611
3202
2.63
229.62
1.4
1.3
mg/l
485.1
570.3
2.38
1542
3066
(3009542) Hematocrit [Volume Fraction] of Blood
38074
177442
1.48
229.57
18.3
11.4
%
39.9
40.3
13.45
28078
136004
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
6301
20808
1.63
227.89
2.3
1.8
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
2669
6736
2.09
225.29
2.4
2.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
1635
3312
2.58
224.68
1.3
1.2
u/ml
5.6
10.2
2.05
274
452
(3016502) Oxygen saturation in Arterial blood
4575
13919
1.76
222.83
8.1
7.6
%
95.4
95.7
2.22
4427
13355
(4024509)
695
787
4.57
222.13
1.6
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
2067
4715
2.30
221.97
4.6
2.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
1613
3269
2.58
221.41
1.3
1.2
u/ml
4.5
10.3
1.18
163
301
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2019
4562
2.32
221.41
2.3
2.1
g/l
7.4
7.4
0.25
1523
3541
(3009214) Lutropin [Units/volume] in Serum or Plasma
2181
5107
2.24
220.68
1.6
1.3
u/l
8.7
9.0
0.41
1754
4159
(3017446) Testosterone [Moles/volume] in Serum or Plasma
4542
13842
1.75
219.78
2.6
2.0
nmol/l
12.1
12.8
6.32
3942
12498
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2012
4559
2.32
219.24
2.3
2.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2009
4553
2.31
218.82
2.3
2.1
g/l
3.7
4.0
6.66
1454
3374
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
2455
6083
2.12
216.84
4.6
3.6
%
50.6
47.8
5.71
2426
6022
(3035350) Ketones [Presence] in Urine by Test strip
20130
84602
1.38
216.78
4.1
3.0
estimate
0.0
0.0
0.58
3073
16870
(3044889) 12 lead EKG panel
27108
119584
1.37
215.60
3.9
3.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
1363
2563
2.77
214.91
1.3
1.2
u/ml
4.1
6.9
0.57
107
193
(46235355) HIV 1 and 2 tests - Meaningful Use set
9893
36694
1.48
212.71
2.1
1.8
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
1852
4114
2.36
210.62
1.8
1.6
g/l
1.2
1.2
1.78
1774
3949
(3000991) Gas panel - Venous blood
4188
12618
1.77
210.13
9.5
7.9
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
790
1052
3.89
208.80
1.8
1.5
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
1800
3985
2.36
206.14
1.9
1.6
g/l
0.2
0.2
2.40
1726
3813
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
1108
1897
3.04
204.69
1.4
1.3
u/l
23.0
25.8
1.64
860
1617
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
1416
2805
2.63
202.85
1.3
1.2
mmol/l
3.8
3.7
1.47
1342
2649
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1887
4305
2.30
202.26
2.4
2.1
g/l
3.0
3.1
2.79
1482
3491
(3021589) Normoblasts [#/volume] in Blood
18456
77091
1.37
201.41
10.0
8.7
e9/l
0.0
0.0
0.00
15718
61469
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6767
23383
1.56
200.68
2.4
1.9
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
1895
4351
2.28
200.19
2.3
2.1
g/l
10.3
10.4
0.76
1594
3702
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
1643
3537
2.43
199.56
2.2
2.0
mg/l
11.5
10.3
4.93
1515
3348
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
732
956
3.97
198.21
1.9
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
2023
4837
2.19
194.46
1.8
1.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
20175
85931
1.35
190.86
4.1
3.0
estimate
0.0
0.0
0.76
3091
16710
(3015171) Extractable nuclear Ab [Units/volume] in Serum
2174
5408
2.11
189.58
1.3
1.2
u/ml
1.0
0.7
0.61
207
516
(3035637) Corticotropin [Mass/volume] in Plasma
959
1573
3.17
189.48
1.6
1.5
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
1345
2692
2.60
188.82
3.2
2.4
umol/l
33.2
35.1
1.20
1173
2199
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
1351
2711
2.60
188.73
1.6
1.4
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
1028
1777
3.01
186.90
2.2
1.7
titre
5.8
3.0
0.63
34
24
(3021601) Nitrite [Presence] in Urine by Test strip
19953
85037
1.35
186.46
5.6
4.1
estimate
0.0
0.0
5.11
3157
17225
(3008757) Leukocyte morphology finding [Identifier] in Blood
813
1206
3.49
186.17
3.9
3.4
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
1043
1841
2.94
183.20
5.5
4.6
umol/l
369.4
364.4
0.43
895
1574
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
7547
27279
1.49
180.13
2.8
3.2
mmol/l
2.4
2.4
9.51
6601
23644
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
848
1337
3.29
177.85
2.3
1.8
mg/l
22.9
28.9
1.74
182
417
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
8208
30314
1.47
175.57
1.8
1.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
4504
14521
1.65
175.48
3.5
4.3
ug/l
18.8
31.4
1.71
3578
11574
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
631
807
4.04
175.30
1.8
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
631
807
4.04
175.30
1.8
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
631
807
4.04
175.30
1.8
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
3228
9500
1.79
173.60
1.2
1.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
1072
1990
2.80
172.68
3.4
2.9
%
1.4
1.5
0.41
753
1622
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
8727
32736
1.45
171.77
1.6
1.7
pmol/l
21816849.7
35529843.4
1.58
7201
27124
(3014271) Vancomycin [Susceptibility]
451
433
5.38
170.44
3.1
2.7
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
610
782
4.03
168.98
1.3
1.2
u/ml
36.9
55.7
0.58
33
31
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
1218
2462
2.57
167.63
1.2
1.2
titre
94.4
99.5
0.06
25
37
(3024980) IgG subclass 4 [Mass/volume] in Serum
1084
2065
2.73
166.71
1.7
1.5
g/l
0.8
0.9
0.46
860
1429
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
571
701
4.21
166.58
3.2
2.2
e6/l
684.3
672.3
0.11
258
259
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
1356
2909
2.43
165.59
1.3
1.2
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
867
1456
3.09
165.05
1.9
1.6
titre
1843.6
4869.3
0.68
44
30
(44816559) Phosphatidylethanol [Mass/volume] in Blood
1301
2742
2.47
164.77
1.4
1.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
1663
3926
2.21
164.32
1.3
1.2
titre
98.7
129.8
0.83
145
396
(3015736) pH of Urine
15703
65443
1.34
163.51
3.9
2.8
ph
5.8
5.8
0.18
18
63
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
593
766
4.00
162.76
1.3
1.2
u/ml
79.7
67.0
0.35
31
35
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
594
769
3.99
162.59
1.3
1.2
u/ml
29.8
47.0
0.92
49
43
(1001926) Buprenorphine [Presence] in Urine by Screen method
2224
5909
1.97
162.44
3.3
1.8
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
1625
3850
2.20
159.16
1.3
1.2
titre
702.7
1189.1
1.83
40
102
(3021879) Hepatitis B virus core Ab [Presence] in Serum
4095
13200
1.64
158.78
1.5
1.4
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
1271
2706
2.44
157.62
7.2
3.8
iu/ml
799.3
3637.2
0.65
206
287
(3027273) Bicarbonate [Moles/volume] in Venous blood
2418
6683
1.90
157.61
4.5
2.9
mmol/l
25.2
25.3
0.43
2353
6469
(3026250) Tacrolimus [Mass/volume] in Blood
408
384
5.48
157.12
38.4
32.3
ug/l
7.4
7.5
0.23
369
355
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
570
734
4.01
157.05
1.3
1.2
u/ml
9.5
8.1
0.12
38
41
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
13851
56985
1.34
155.04
4.9
4.4
ug/l
2.8
3.1
0.87
12318
51297
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
1268
2744
2.40
151.95
1.3
1.2
u/ml
271.9
253.1
1.23
801
1766
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
1562
3713
2.19
151.71
2.2
2.1
g/l
37.9
37.6
1.08
1315
3237
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
395
373
5.46
151.65
2.6
2.2
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
533
670
4.11
151.22
3.2
2.1
e6/l
520.6
509.6
0.14
447
532
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
518
637
4.20
150.84
3.3
2.1
e9/l
0.2
0.2
0.53
445
535
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
2029
5362
1.98
150.20
1.6
1.7
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
3846
12366
1.64
150.17
4.7
3.6
%
0.9
1.0
0.70
1276
3304
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
1318
2928
2.34
149.30
1.6
1.4
e6/l
3735.9
988.7
0.52
1122
2282
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
412
414
5.13
149.06
1.5
1.3
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
936
1750
2.77
148.81
1.3
1.3
nmol/l
0.2
0.2
0.59
58
113
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
412
415
5.12
148.70
1.5
1.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
2481
7057
1.84
147.99
2.7
2.1
u/l
5145.6
6590.4
1.45
955
2890
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
1312
2926
2.33
147.35
1.5
1.4
e6/l
14.8
37.6
2.09
1074
2139
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
1775
4496
2.06
147.17
1.6
1.6
iu/ml
20.8
2.2
0.88
328
930
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
1313
2931
2.33
147.16
1.5
1.3
u/ml
16.1
22.9
0.90
25
47
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
2063
5527
1.95
146.92
2.0
1.6
nmol/l
39.3
40.3
0.99
1958
5444
(3048929) Epstein Barr virus Ab [Presence] in Serum
2025
5390
1.96
146.88
1.3
1.2
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
929
1758
2.74
144.53
1.3
1.3
nmol/l
0.6
2.2
1.13
907
1686
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
431
468
4.75
144.13
2.0
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
431
468
4.75
144.13
2.0
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
431
468
4.75
144.13
2.0
1.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
836
1494
2.90
143.73
1.3
1.3
nmol/l
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
430
468
4.74
143.44
2.0
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
2735
8102
1.77
143.03
3.2
1.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
1673
4194
2.08
142.40
2.8
2.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
12077
76117
0.75
141.28
2.6
2.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
1307
2967
2.29
141.09
1.6
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
2751
8197
1.76
141.02
3.2
1.7
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
1629
4061
2.09
140.63
2.4
2.4
g/l
0.9
0.9
0.04
1408
3476
(3027008) Opiates [Presence] in Urine
2743
8173
1.76
140.61
3.1
1.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
654
1016
3.33
140.17
3.3
2.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
2558
7499
1.79
138.34
3.3
1.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
8890
34614
1.39
137.76
4.6
3.2
kg/l
1.0
1.0
0.59
1544
5122
(3021440) Promyelocytes/100 leukocytes in Blood
3661
11877
1.63
137.47
4.7
3.7
%
0.1
0.1
0.16
1201
3086
(4198724)
459
552
4.29
137.19
2.7
1.7
—
—
—
0
0
(3036489) Thrombin time
2093
5778
1.89
136.48
2.6
1.9
s
21.3
21.4
0.04
1829
5020
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
2770
8356
1.74
136.01
1.1
1.0
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
506
674
3.88
133.71
12.7
11.8
mmol/l
0.6
0.6
0.27
467
608
(3044927) Protein electrophoresis panel - Urine
622
966
3.33
133.38
1.2
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
479
616
4.01
132.23
1.4
1.3
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
968
1970
2.55
131.33
3.7
2.1
u/ml
842.6
3839.4
1.86
56
103
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
3527
11480
1.62
130.42
1.3
1.2
iu/ml
134.3
149.9
1.26
1159
4537
(3021387) Prolactin [Units/volume] in Serum or Plasma
2297
6654
1.81
128.91
1.7
1.6
mu/l
329.3
298.2
2.23
2095
5916
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
1496
3732
2.09
128.80
2.1
1.8
pmol/l
193.3
200.9
1.64
1428
3563
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
840
1603
2.71
128.69
1.3
1.3
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
386
422
4.71
128.20
29.5
23.6
ug/l
111.2
127.4
2.17
317
364
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
807
1510
2.77
128.09
6.9
5.4
mg/l
11.2
11.2
0.20
736
1382
(3025941) Bacteria identified in Stool by Culture
2943
9182
1.68
127.91
1.3
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
468
608
3.97
127.61
1.5
1.3
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
755
1367
2.86
126.93
1.1
1.1
au/ml
1.3
8.1
—
5
9
(3002173) Hemoglobin [Mass/volume] in Arterial blood
3938
13250
1.57
126.78
9.0
7.9
g/l
122.1
122.6
0.76
3829
12738
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
1236
2870
2.24
126.64
1.3
1.2
u/ml
40.0
47.3
0.62
107
286
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
1527
3881
2.05
125.24
3.4
3.1
ratio
3.5
5.0
0.25
116
225
(3002179) Metamyelocytes/100 leukocytes in Blood
3482
11409
1.61
125.14
4.5
3.5
%
0.7
0.6
0.78
877
2502
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
1562
4007
2.03
125.01
3.4
3.1
mg/l
37.3
43.9
1.05
1400
2928
(3026782) Osmolality of Urine
8136
31674
1.38
124.48
3.2
2.4
mosm/kgh2o
544.0
560.1
7.63
7044
26713
(3034860) Kappa light chains.free [Mass/volume] in Serum
1562
4019
2.02
124.01
3.5
3.1
mg/l
57.2
62.9
0.24
1409
2936
(3011412) CD3 cells [#/volume] in Blood
657
1117
3.04
122.64
3.0
2.1
e9/l
1.3
1.1
3.77
323
750
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
465
625
3.84
121.51
1.3
1.3
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
651
1107
3.04
121.48
1.6
1.4
promille
1.6
1.4
2.11
506
826
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
1438
3617
2.07
121.14
2.3
2.2
g/l
0.0
0.0
0.54
1324
3307
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
731
1335
2.83
121.09
1.1
1.1
au/ml
87.9
63.2
—
8
11
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
1509
3869
2.03
120.90
1.2
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
631
1056
3.09
120.79
1.1
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
612
1012
3.12
119.38
1.2
1.1
mg/l
35.8
45.7
5.61
546
810
(3016244) Insulin [Units/volume] in Serum or Plasma
517
765
3.49
118.84
3.4
3.0
mu/l
25.0
28.1
0.87
466
732
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
452
608
3.83
118.01
1.1
1.1
nmol/l
4.3
8.7
0.83
72
144
(3004119) Hemoglobin [Mass/volume] in Venous blood
2799
8802
1.67
117.83
4.1
2.9
g/l
129.8
131.1
2.03
2739
8597
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
1052
2354
2.32
117.15
1.1
1.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
1683
4540
1.93
117.13
3.6
2.9
u/ml
0.3
0.4
0.62
989
2451
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
1366
3413
2.08
117.04
2.3
2.2
g/l
0.0
0.0
0.05
1256
3113
(3044290) Cell count panel - Cerebral spinal fluid
1213
2895
2.18
116.44
1.5
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
1174
2766
2.20
116.22
1.6
1.3
u/ml
106.4
104.6
0.25
193
669
(3027944) Amphetamines [Presence] in Urine
2624
8140
1.69
116.13
2.8
1.6
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
1588
4212
1.96
115.93
1.4
1.3
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
585
963
3.14
114.93
1.1
1.1
mg/l
247.2
265.0
0.99
544
830
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
1344
3372
2.07
113.91
2.3
2.2
g/l
0.0
0.0
0.00
1253
3105
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
717
1341
2.76
113.90
3.2
3.3
nmol/l
6.7
9.1
0.23
698
1308
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
1689
4613
1.91
113.35
3.3
2.3
g/l
3.5
3.7
4.55
1624
4407
(42529406) Shigella sp [Presence] in Stool by Culture
1545
4097
1.96
112.83
1.2
1.1
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
1639
4445
1.92
112.27
3.2
2.2
%
179.6
187.9
3.00
1570
4219
(3014765) Yersinia sp identified in Stool by Organism specific culture
1541
4090
1.96
112.26
1.2
1.1
—
—
—
0
0
(4062490)
690
1276
2.80
111.83
1.5
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
9601
38938
1.33
110.98
5.1
3.9
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
688
1277
2.78
110.79
1.5
1.3
g/l
2.9
3.0
1.37
526
755
(3027135) IgG subclass 1 [Mass/volume] in Serum
688
1279
2.78
110.48
1.5
1.3
g/l
6.9
7.0
0.26
524
754
(3024139) IgG subclass 3 [Mass/volume] in Serum
687
1277
2.78
110.34
1.5
1.3
g/l
0.4
0.4
1.65
530
751
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
330
359
4.73
110.24
2.2
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
330
359
4.73
110.24
2.2
1.9
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
1821
5147
1.84
110.15
2.5
2.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
1525
4066
1.95
109.65
1.2
1.1
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
2254
6814
1.73
109.24
3.5
2.6
%
1.3
1.3
1.05
2237
6778
(21494815) CD4 cells/100 lymphocytes in Specimen
607
1060
2.96
108.49
2.6
2.0
%
41.3
40.8
0.08
105
95
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
330
367
4.63
107.69
2.2
1.9
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
471
702
3.46
107.21
3.0
3.6
nmol/l
135.5
125.8
0.17
463
691
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
568
964
3.04
106.36
1.1
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
2725
8742
1.63
105.93
4.8
4.4
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
2814
9110
1.62
105.50
10.2
9.1
%
0.7
0.7
0.27
2793
9059
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2812
9114
1.62
104.93
10.1
9.0
%
1.4
1.3
3.28
2789
9055
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
2203
6700
1.72
104.44
3.5
2.6
%
0.7
0.7
3.26
2122
6387
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
734
1461
2.60
103.95
1.4
1.3
nmol/l
29.7
22.0
—
10
8
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
1745
4985
1.82
101.98
2.9
2.0
%
92.4
91.6
0.61
1653
4603
(3019420) Tryptase [Mass/volume] in Serum or Plasma
382
506
3.89
101.76
1.6
1.6
ug/l
8.5
7.2
0.50
352
444
(40761536) Microorganisms panel - Urine sediment
2363
18935
0.62
101.56
4.5
3.3
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
2802
9161
1.60
100.81
10.3
9.2
%
94.0
93.8
0.75
2789
9129
(40760888) Immunoglobulin light chains.free panel - Serum
1179
2958
2.07
99.86
3.6
3.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
1237
3164
2.03
99.60
1.8
1.5
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
272
272
5.15
99.02
3.8
2.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
1021
2444
2.16
97.26
1.6
1.6
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
2395
7599
1.65
96.96
3.0
2.4
e6/l
0.3
0.3
0.18
2347
7368
(3027923) C peptide [Moles/volume] in Serum or Plasma
400
571
3.61
96.68
1.7
1.6
nmol/l
1.3
1.2
0.28
264
481
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
1157
2935
2.04
95.20
2.9
1.6
nmol/l
0.9
0.8
1.02
891
2581
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
633
1228
2.66
94.12
1.1
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
757
1612
2.43
93.73
2.5
2.4
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
1996
6090
1.71
93.36
1.1
1.1
u/ml
16.0
8.1
0.34
42
83
(3000475) Leukocytes [#/volume] in Synovial fluid
1228
3212
1.98
93.04
1.6
1.6
e6/l
14522.6
13676.2
0.20
939
2259
(3013005) Retinol [Moles/volume] in Serum or Plasma
339
439
3.98
92.92
2.2
1.5
umol/l
2.0
2.0
0.05
309
410
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
721
1507
2.47
92.75
1.2
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
3296
11397
1.52
92.65
4.8
3.7
%
0.3
0.2
0.33
942
2743
(3032057) Clostridioides difficile [Presence] in Stool
211
174
6.23
91.44
1.8
1.8
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
1319
3562
1.92
91.31
3.7
2.9
kpa
8.5
8.3
2.02
1196
3393
(3020961) Endomysium IgA Ab [Titer] in Serum
2387
7685
1.62
91.14
1.1
1.1
titre
215.8
249.5
0.20
58
233
(3042733) HLA Ab [Presence] in Serum
295
347
4.37
90.59
4.8
5.3
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
1243
3321
1.94
88.72
1.5
1.2
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
359
505
3.66
88.54
1.1
1.1
u/ml
7.8
7.9
0.03
78
86
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
905
2151
2.18
87.69
1.1
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
3468
24982
0.69
87.37
1.3
1.3
—
—
—
0
0
(44806118)
620
1240
2.58
87.05
1.7
1.4
—
—
—
0
0
(44790049)
620
1241
2.58
86.91
1.7
1.4
—
—
—
0
0
(44790047)
620
1242
2.58
86.78
1.7
1.4
—
—
—
0
0
(44790048)
620
1242
2.58
86.78
1.7
1.4
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
415
662
3.23
85.66
1.0
1.0
ng/l
302.0
330.2
0.84
248
523
(3003181) Sodium [Moles/volume] in Urine
885
2110
2.17
85.12
1.4
1.4
mmol/l
62.4
62.7
0.07
676
1646
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
376
567
3.42
84.28
3.0
2.5
%
38.2
39.3
0.26
105
176
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
414
667
3.20
84.19
1.0
1.0
ng/l
40.9
41.9
0.14
241
518
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
1457
4176
1.81
84.10
4.9
2.8
mg/l
1.5
1.5
0.58
1336
3855
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
413
666
3.19
83.87
1.4
1.4
u/l
6.4
5.9
0.36
350
567
(3048879) Bone marrow aspiration report
234
238
5.06
83.85
1.9
1.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
1005
2536
2.05
83.83
1.7
1.6
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
517
959
2.78
83.43
1.1
1.1
mg/l
280.6
286.5
0.90
460
870
(3015235) Bicarbonate [Moles/volume] in Capillary blood
1267
3481
1.89
83.34
3.3
2.9
mmol/l
24.3
24.8
3.66
1068
3191
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
412
668
3.18
82.98
1.0
1.0
ng/l
746.9
719.3
0.46
239
503
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
869
2079
2.16
82.89
1.3
1.2
u/l
40.9
28.1
1.65
744
1798
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
1479
4291
1.79
82.06
1.1
1.1
u/ml
7.3
4.7
0.58
153
727
(3000093) Morphology [Interpretation] in Blood Narrative
595
1202
2.55
81.95
1.2
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
2056
6547
1.64
81.80
1.2
1.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
799
1857
2.22
81.64
1.1
1.1
g/l
1.5
1.5
0.59
707
1696
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
469
841
2.87
80.29
1.3
1.2
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
519
986
2.71
80.26
1.3
1.2
mmol/l
2.0
2.1
1.54
482
919
(3024932) HLA-DR beta [Type]
284
359
4.07
80.25
1.1
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
465
834
2.87
79.58
1.3
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
287
369
4.00
79.45
1.0
1.0
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
179
144
6.39
79.23
1.4
1.2
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
341
508
3.46
77.81
2.7
1.6
umol/l
141.3
114.0
0.66
169
249
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
1573
4730
1.73
77.28
1.9
1.7
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
929
2350
2.04
76.99
1.3
1.2
u/ml
3.6
3.8
0.27
410
1072
(3045424) Erythrocytes [Presence] in Urine
883
2198
2.08
76.30
1.4
1.4
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
489
936
2.69
74.63
2.4
1.9
%
72.6
72.3
0.16
465
907
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
1303
3745
1.80
74.49
1.8
1.9
iu/l
4.4
23.8
0.70
471
1423
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
390
657
3.06
74.04
2.7
2.7
u/ml
901.9
1048.0
0.36
385
651
(3003338) MCHC [Mass/volume]
34463
166084
1.22
73.74
22.5
13.1
g/l
332.6
333.2
25.58
34212
164531
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
428
766
2.88
73.55
2.9
1.7
%
96.2
97.8
0.36
411
714
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
8472
35418
1.27
73.48
1.7
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
971
2543
1.98
73.29
1.1
1.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
730
1713
2.20
72.96
1.3
1.2
u/ml
50.4
51.1
0.02
38
112
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
494
963
2.64
72.89
21.8
16.3
nmol/l
3331.7
2966.0
0.05
482
927
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
477
915
2.69
72.52
15.0
11.3
nmol/l
817.3
1922.4
0.51
470
879
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
480
924
2.68
72.51
2.4
1.9
%
13.0
13.8
0.52
235
353
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
1131
3134
1.87
72.48
1.9
1.5
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
532
1086
2.53
71.84
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
531
1085
2.52
71.57
1.2
1.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
317
476
3.43
71.57
2.2
1.4
umol/l
27.4
29.4
2.34
301
455
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
531
1086
2.52
71.44
1.2
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
391
675
2.98
71.38
2.0
1.5
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
1530
4672
1.70
71.13
4.5
4.0
mmol/l
1.4
1.4
0.37
1495
4596
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
194
193
5.16
71.13
2.1
2.0
umol/l
16.6
17.5
0.39
194
193
(3014148) Varicella zoster virus Ab [Titer] in Serum
833
2085
2.06
70.98
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
524
1075
2.51
70.08
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
524
1075
2.51
70.08
1.2
1.2
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
340
544
3.22
69.96
1.8
1.3
umol/l
23.9
29.0
1.76
317
514
(3019832) Treponema pallidum Ab [Presence] in Serum
5234
20629
1.34
69.87
1.8
1.6
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
524
1077
2.51
69.82
1.2
1.1
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
710
1682
2.18
69.39
1.1
1.1
iu/ml
2.4
2.0
0.20
13
30
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
799
1986
2.08
69.32
1.3
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
257
338
3.91
69.25
1.2
1.1
—
—
—
0
0
(4027681)
428
794
2.78
69.14
1.2
1.3
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
143
103
7.13
69.01
5.3
6.7
%
63.1
73.4
2.20
103
75
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
2849
10140
1.47
68.92
2.0
1.6
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
1695
5394
1.63
67.43
5.0
4.5
%
1.7
1.7
0.23
1614
5018
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
518
1079
2.47
67.21
1.2
1.1
u/ml
29.0
81.9
—
5
12
(3010503) CD19 cells [#/volume] in Blood
409
753
2.80
66.98
3.2
2.2
e9/l
0.2
0.3
0.22
393
736
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
277
396
3.60
66.98
1.5
1.4
pmol/l
15.1
15.0
0.02
226
343
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
296
444
3.43
66.97
3.3
2.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
837
2147
2.01
66.87
1.1
1.1
—
—
—
0
0
(3008898) HLA-B27 [Presence]
1771
5725
1.61
66.17
1.1
1.1
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
251
336
3.84
66.17
2.1
1.4
u/ml
1088.4
1858.0
0.60
32
37
(3011985) Renin [Units/volume] in Plasma
764
1901
2.08
66.12
1.6
1.5
mu/l
66.8
67.5
0.02
673
1700
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
2884
10386
1.45
65.57
8.3
6.4
mmol/l
24.9
24.7
2.34
2872
10280
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
155
133
5.98
65.09
2.7
2.4
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
147
119
6.34
64.81
3.0
3.8
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
929
2504
1.92
64.64
1.2
1.2
u/ml
3.5
3.8
0.18
320
895
(3043409) Potassium [Moles/volume] in Arterial blood
1332
4020
1.72
64.54
4.8
4.2
mmol/l
3.9
3.9
2.04
1276
3667
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
357
624
2.94
63.91
1.6
1.5
iu/ml
1875314.6
1741640.9
0.08
43
38
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
415
791
2.70
63.90
1.4
1.2
umol/l
5.1
5.5
0.74
378
744
(3045716) Anion gap in Serum or Plasma
248
339
3.76
63.67
2.5
2.5
mmol/l
8.9
9.7
1.44
196
192
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
443
877
2.60
63.56
1.7
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
1271
3802
1.73
63.53
1.5
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
834
2178
1.98
63.47
1.3
1.2
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
74
15
25.30
63.41
1.0
1.0
—
—
—
0
0
(4015189)
204
238
4.40
63.39
2.2
2.0
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
3510
13181
1.39
63.19
2.2
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
1761
5750
1.59
63.12
1.4
1.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
474
977
2.50
62.86
1.1
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
1474
4611
1.66
62.62
3.6
3.0
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
900
2428
1.92
62.47
1.9
1.5
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
580
1324
2.26
61.86
1.7
1.4
mosm/kgh2o
282.6
279.6
1.85
431
1045
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
309
505
3.15
61.62
1.1
1.1
ng/l
457.0
519.2
0.09
54
135
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
167
167
5.14
60.99
5.5
4.9
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
1091
3161
1.79
60.75
3.8
2.8
mmol/l
1.5
1.6
4.58
1069
3098
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
293
467
3.23
60.72
2.0
2.5
ug/l
0.9
1.2
1.82
273
437
(4306422)
875
2365
1.91
60.41
1.2
1.2
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
230
312
3.79
59.67
2.3
1.5
u/l
37.9
33.6
0.14
211
276
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
755
1946
2.00
59.58
3.0
2.5
u/ml
105.0
698.2
2.12
734
1801
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
376
707
2.74
59.38
1.1
1.1
u/l
1.0
1.1
0.80
169
335
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
892
2442
1.89
59.31
1.1
1.1
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
1633
5315
1.59
59.28
5.1
4.5
%
0.8
0.9
6.62
1558
4939
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
937
2614
1.85
58.84
1.1
1.1
iu/ml
2415.0
749.8
0.56
229
570
(3006245) CD3-CD19+ cells/100 cells in Blood
263
399
3.39
58.62
2.7
1.8
%
11.4
10.6
0.33
244
376
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
257
384
3.44
58.54
2.7
1.7
%
30.1
29.2
0.35
240
365
(3002256) Pathology report gross observation
5460
22176
1.29
57.97
1.3
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
429
879
2.51
57.62
1.0
1.0
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
1687
5579
1.57
57.25
1.3
1.3
miu/ml
215.3
229.0
0.77
717
2692
(3045142) Bone marrow Pathology biopsy report
597
1429
2.15
56.98
1.4
1.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
723
1868
2.00
56.70
1.4
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
1265
3902
1.68
56.63
1.3
1.2
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
330
593
2.86
56.46
1.9
1.7
%
148.2
143.0
0.46
315
558
(3003888) Timothy IgE Ab [Units/volume] in Serum
1083
3219
1.74
55.34
1.1
1.1
u/ml
5.5
5.8
0.22
657
1577
(3004716) Salmonella sp identified in Stool by Organism specific culture
2461
8876
1.44
55.27
1.4
1.4
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
846
2330
1.87
55.27
1.1
1.1
%
116.6
117.7
0.45
780
2097
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
1558
5105
1.58
54.97
3.0
3.6
u/ml
864.0
2749.8
0.83
1345
4391
(3023323) Follitropin [Units/volume] in Serum or Plasma
2376
8526
1.45
54.80
1.5
1.3
iu/l
23.2
27.2
7.38
2040
7226
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
548
1287
2.19
54.77
1.5
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
436
924
2.43
54.71
1.3
1.2
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
529
1225
2.23
54.65
3.8
3.7
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
489
1101
2.29
53.87
1.8
2.1
g/24h
1.0
0.9
0.18
33
68
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
421
884
2.45
53.85
2.4
1.9
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
693
1799
1.99
53.67
1.4
1.3
pmol/l
350.5
276.9
0.93
521
1432
(3038515) Glucose [Moles/volume] in Venous blood
1032
3060
1.74
53.18
3.9
2.9
mmol/l
7.3
7.7
3.92
1012
3004
(4268621)
638
1618
2.03
52.63
2.3
2.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
1007
2975
1.75
52.55
3.8
2.9
—
—
—
0
0
(3000492) Spirometry study
4316
17202
1.31
52.32
1.5
1.4
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
173
208
4.27
52.05
1.6
1.4
ug/l
0.4
0.5
0.21
113
140
(3000060) B lymphocytes [#/volume] in Blood
209
293
3.66
52.01
2.9
1.7
e6/l
502.6
1458.1
0.51
123
145
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
296
525
2.90
51.83
1.4
1.4
mu/l
475.6
856.5
1.04
276
503
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
301
540
2.87
51.69
1.4
1.4
%
72.6
72.9
0.09
281
518
(3006922) Hepatitis E virus Ab [Presence] in Serum
463
1040
2.29
51.30
1.1
1.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
185
240
3.96
50.85
1.2
1.3
—
—
—
0
0
(3020891) Body temperature
1676
5687
1.53
50.73
5.6
4.5
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
579
1438
2.08
50.46
1.9
1.5
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
430
943
2.35
50.23
1.1
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
141
145
4.99
50.18
1.1
1.0
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
2320
8426
1.43
50.10
7.8
6.5
mmol/l
24.5
24.5
0.08
2178
7761
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
430
947
2.34
49.78
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
429
944
2.34
49.76
1.2
1.1
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
85
46
9.48
49.59
3.4
2.3
mg/l
2.1
2.5
0.59
73
37
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
333
650
2.64
49.20
1.3
1.2
titre
63.4
104.6
0.54
32
48
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
377
785
2.47
49.11
1.5
1.5
u/ml
22.5
25.9
0.52
81
157
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
561
1394
2.07
48.84
1.3
1.2
u/l
64.0
71.0
0.64
355
967
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
847
2429
1.80
48.81
1.2
1.1
au/ml
11.3
11.8
0.04
46
195
(4035726)
3621
14224
1.33
48.43
1.4
1.4
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
169
212
4.09
48.42
1.3
1.3
mu/l
135.7
66.3
0.77
116
167
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
305
575
2.73
48.06
1.1
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
620
1611
1.98
47.95
1.5
1.4
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
618
1604
1.99
47.94
1.1
1.0
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
340
682
2.56
47.71
1.3
1.2
titre
400.5
498.2
0.14
20
57
(3035285) Chloride [Moles/volume] in Venous blood
675
1812
1.92
47.62
2.7
2.1
mmol/l
105.7
105.6
0.04
670
1794
(3041354) Potassium [Moles/volume] in Venous blood
675
1812
1.92
47.62
2.7
2.1
mmol/l
4.0
4.1
0.61
670
1795
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
347
706
2.53
47.36
1.5
1.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
286
528
2.78
46.80
4.2
13.5
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
133
140
4.88
46.27
1.1
1.1
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
130
134
4.98
46.20
1.4
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
1095
3445
1.64
45.51
2.2
2.4
ug/min
120.6
115.9
0.10
640
2050
(3027456) Digoxin [Moles/volume] in Serum or Plasma
802
2313
1.79
45.40
3.1
2.9
nmol/l
0.8
0.8
0.02
545
1828
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
239
404
3.04
45.36
1.3
1.2
g/l
0.3
0.3
0.13
209
313
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
342
708
2.48
45.13
1.1
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
1014
3137
1.67
44.93
1.1
1.1
u/ml
0.8
1.2
2.29
510
1248
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
303
591
2.64
44.89
1.9
1.5
nmol/l
11.6
4.9
0.39
247
496
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
182
258
3.62
44.71
1.3
1.2
pmol/l
372.1
331.4
0.17
123
198
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
10230
45611
1.19
44.34
3.9
3.9
%
21.9
21.9
0.02
4757
20974
(3037692) Legionella sp identified in Specimen by Organism specific culture
221
361
3.15
44.28
1.5
1.3
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
476
1154
2.12
44.16
1.2
1.2
titre
160.7
206.0
0.55
81
179
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
474
1150
2.12
43.89
1.2
1.2
titre
185.0
149.7
0.12
12
34
(3034426) Prothrombin time (PT)
258
466
2.85
43.89
1.2
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
198
303
3.36
43.74
1.1
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
1062
3350
1.64
43.70
1.4
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
1062
3352
1.64
43.60
1.4
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
32592
158762
1.16
43.57
20.7
13.2
%
13.7
13.6
14.09
32112
154565
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
285
547
2.68
43.52
2.5
2.3
nmol/l
159.9
149.0
0.59
259
445
(3042111) Morphology [Interpretation] in Bone marrow Narrative
737
2099
1.81
43.47
1.7
1.6
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
131
145
4.64
43.28
1.7
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
657
1806
1.88
43.26
2.7
2.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
170
235
3.71
43.20
1.1
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
194
297
3.35
42.84
1.1
1.1
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
631
1717
1.89
42.83
1.2
1.1
%
95.4
96.9
0.70
593
1612
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
171
239
3.67
42.83
1.3
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
232
400
2.98
42.68
1.4
1.4
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
219
365
3.08
42.55
1.3
1.2
%
111.2
110.3
0.17
204
327
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
501
1264
2.04
42.01
1.4
1.3
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
352
766
2.36
41.92
1.3
1.2
u/l
92.8
86.2
0.44
310
662
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
196
307
3.28
41.88
1.1
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
397
913
2.24
41.81
1.8
1.6
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
77
47
8.40
41.78
2.8
1.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
195
305
3.28
41.75
1.1
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
1128
3657
1.59
41.60
1.1
1.1
u/ml
1.1
1.9
2.15
567
1397
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
432
1036
2.15
41.20
2.1
1.6
mg/l
3.7
3.8
0.17
407
979
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
921
2843
1.67
41.17
1.6
1.4
nmol/l
0.3
0.4
1.35
726
2266
(3017704) Immunofixation for Urine
279
546
2.63
41.13
1.7
1.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
335
719
2.40
41.09
1.1
1.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
623
1719
1.87
40.59
2.2
1.8
ug/l
19.6
27.4
3.88
603
1698
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
1435
4949
1.50
40.24
1.5
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
12023
54712
1.17
39.93
1.5
1.5
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
339
742
2.35
39.90
1.3
1.2
u/l
21.5
24.1
0.48
296
633
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
243
449
2.78
39.79
1.4
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
184
287
3.29
39.59
1.1
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
272
538
2.60
39.32
1.8
1.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
194
316
3.15
39.11
1.5
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
798
2405
1.71
38.94
1.5
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
576
1571
1.89
38.88
3.0
2.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
268
531
2.59
38.63
1.1
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
7615
33423
1.20
38.54
2.9
2.8
ug/l
0.7
0.8
3.99
5050
20559
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
64
33
9.94
38.43
4.3
4.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
423
1036
2.10
38.33
1.3
1.2
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
243
460
2.71
38.14
2.0
1.7
%
176.3
161.6
0.95
237
424
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
136
175
3.99
37.90
1.7
1.2
ng/l
672.3
98.7
0.49
93
116
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
105
107
5.03
37.82
2.2
1.9
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
899
2821
1.64
37.80
1.5
1.5
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
197
334
3.03
37.32
1.3
1.2
g/l
39.6
40.7
0.37
108
186
(3033923) Metanephrine [Moles/time] in 24 hour Urine
147
205
3.68
37.00
1.1
1.1
umol/24h
0.7
0.9
0.33
64
107
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
136
179
3.90
36.87
1.3
1.2
—
—
—
0
0
(4094501)
1224
4158
1.52
36.86
1.1
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
414
1023
2.08
36.71
1.7
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
246
480
2.63
36.54
1.9
1.9
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
458
1180
2.00
36.39
1.2
1.1
nmol/l
347.1
393.1
4.11
381
986
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
423
1062
2.05
36.01
1.4
1.4
umol/l
12.4
12.0
0.47
396
1015
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
274
571
2.47
35.80
1.1
1.2
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
211
384
2.82
35.55
1.0
1.0
u/ml
10.5
10.9
0.04
29
46
(21494890) Protein electrophoresis panel - 24 hour Urine
484
1286
1.94
35.31
2.2
1.9
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
94
92
5.24
35.25
2.3
2.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
1168
3972
1.52
35.01
4.8
3.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
235
458
2.64
35.01
1.1
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
267
556
2.47
34.96
1.1
1.1
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
883
2829
1.61
34.24
2.6
3.9
u/ml
603.1
1016.6
0.63
789
2589
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
120
153
4.02
33.87
1.2
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
122
158
3.96
33.79
1.8
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
167
273
3.14
33.57
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
167
273
3.14
33.57
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
167
273
3.14
33.57
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
167
273
3.14
33.57
1.1
1.1
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
144
213
3.47
33.52
1.6
1.3
nmol/l
0.2
0.3
0.33
107
143
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
615
1798
1.76
33.41
1.1
1.1
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
297
665
2.30
33.36
2.3
2.3
ug/l
110.1
294.6
0.53
286
632
(3051651) Icteric interference index of Serum or Plasma
345
826
2.15
33.16
4.1
3.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
800
2522
1.64
33.09
1.2
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
648
1931
1.73
32.98
1.5
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
349
844
2.13
32.74
1.2
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
713
2187
1.68
32.73
1.3
1.3
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
395
1003
2.03
32.70
1.5
1.2
u/ml
1.2
1.4
0.17
219
329
(3016038) Potassium [Moles/volume] in Urine
338
809
2.15
32.52
1.3
1.2
mmol/l
32.6
35.4
1.25
274
706
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
224
444
2.59
32.37
1.1
1.1
%
91.4
92.1
0.10
108
196
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
2050
7845
1.35
32.34
11.5
9.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
777
2456
1.63
31.83
2.3
2.2
umol/l
7.9
6.3
1.00
553
1801
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
224
449
2.56
31.69
1.1
1.2
%
108.7
106.8
0.28
211
405
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
219
435
2.59
31.53
1.1
1.2
%
90.2
92.6
0.33
107
196
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
145
226
3.29
31.35
1.4
1.5
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
288
656
2.26
31.17
2.1
2.1
umol/l
39.5
49.9
0.28
35
79
(3010726) Horse dander IgE Ab [Units/volume] in Serum
942
3139
1.55
30.99
1.1
1.1
u/ml
1.9
2.4
0.71
260
780
(3007916) DNA double strand Ab [Titer] in Serum
104
127
4.20
30.94
1.4
1.3
titre
160.0
59.6
—
5
10
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
103
125
4.23
30.86
1.1
1.3
%
43.1
54.5
0.88
37
71
(3010144) Erythrocytes [#/volume] in Synovial fluid
462
1267
1.88
30.80
1.4
1.3
e6/l
157051.8
90582.3
1.04
320
872
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
382
982
2.00
30.63
1.1
1.2
ratio
1.1
1.1
0.73
111
453
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
275
623
2.27
30.15
1.7
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
275
623
2.27
30.15
1.7
1.3
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
265
596
2.28
29.55
2.3
2.3
umol/l
56.5
52.1
1.39
221
488
(3001186) Copper [Moles/volume] in Serum or Plasma
162
282
2.95
29.53
1.6
1.2
umol/l
16.5
16.6
0.09
143
250
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
111
149
3.82
29.46
1.1
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
290
683
2.18
29.08
1.1
1.1
miu/ml
1539.6
1455.5
0.58
290
683
(3024263) Appearance of Synovial fluid
283
660
2.20
29.05
1.7
1.5
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
111
151
3.77
28.97
1.4
1.5
nmol/l
6.2
460473.4
1.73
93
129
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
163
289
2.90
28.83
1.0
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
520
1515
1.77
28.66
3.8
3.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
373
977
1.96
28.46
1.9
1.8
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
14392
67544
1.13
28.40
4.4
3.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
128
198
3.32
28.04
2.6
2.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
465
1319
1.81
27.99
4.7
5.1
u/ml
83.9
98.3
0.23
121
459
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
529
1561
1.74
27.94
1.2
1.1
—
—
—
0
0
(44806071)
116
168
3.54
27.89
1.0
1.1
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
118
175
3.46
27.46
2.3
1.6
pmol/l
46.8
54.3
0.28
105
146
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
354
924
1.97
27.30
1.6
1.4
u/l
12.5
12.4
0.02
341
899
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
604
1863
1.67
27.25
1.6
1.5
%
54.1
57.5
1.12
424
1161
(3029075) Extractable nuclear Ab panel - Serum
200
412
2.49
26.91
1.0
1.1
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
168
317
2.72
26.70
1.3
1.2
nmol/l
122.6
125.1
0.07
131
223
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
92
115
4.10
26.70
1.1
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
109
156
3.58
26.65
1.1
1.1
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
253
584
2.23
26.65
8.0
4.1
mg/l
2044.3
4360.8
0.78
189
400
(3021901) Oxygen saturation in Capillary blood
840
2825
1.53
26.59
3.0
2.7
—
—
—
0
0
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
72
73
5.06
26.19
1.0
1.0
u/ml
0.1
0.1
0.04
43
44
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
746
2455
1.57
25.99
1.1
1.1
u/ml
3.2
2.8
0.32
288
1400
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
129
213
3.11
25.66
1.1
1.2
u/ml
5.9
12.3
0.65
89
152
(3009015) Lactate [Moles/volume] in Synovial fluid
79
91
4.45
25.19
1.3
1.3
mmol/l
6.6
5.9
0.33
36
49
(3024869) Neuronal Ab [Presence] in Serum
125
205
3.13
25.14
1.0
1.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
65
62
5.38
25.08
5.4
4.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
1789
6971
1.33
25.01
1.8
1.6
mg/l
3.9
3.3
1.39
1332
4624
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
427
1225
1.79
24.85
1.5
1.3
nmol/l
1.4
1.4
0.22
388
1112
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
69
72
4.91
24.42
1.5
1.7
mg/l
1.5
1.9
0.21
45
43
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
385
1077
1.84
24.29
3.8
3.3
u/ml
40.6
67.6
1.34
378
1070
(3030313) Adrenal Ab [Titer] in Serum
87
113
3.95
24.15
1.0
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
156
300
2.67
24.01
1.1
1.1
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
126
215
3.01
23.84
1.1
1.3
u/ml
4.8
6.8
0.18
25
48
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
211
473
2.29
23.82
3.1
2.8
umol/l
29.1
28.4
0.37
149
358
(3023420) DNA double strand Ab [Units/volume] in Serum
545
1698
1.65
23.75
1.6
1.5
iu/ml
30.7
29.3
0.08
32
62
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
1969
7833
1.30
23.73
2.9
3.3
u/ml
55.4
49.8
0.31
1884
7587
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
160
314
2.62
23.72
1.2
1.3
%
108.8
107.6
0.14
155
292
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
64
64
5.13
23.64
1.1
1.1
u/ml
22.0
15.6
—
17
9
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
64
64
5.13
23.64
1.1
1.1
u/ml
23.9
20.9
—
12
9
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
534
1657
1.66
23.63
1.1
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
103
155
3.41
23.56
1.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
163
325
2.57
23.46
1.2
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
1275
4762
1.38
23.44
1.2
1.1
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
152
293
2.66
23.31
1.2
1.2
%
74.5
79.7
0.38
43
75
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
154
300
2.63
23.17
1.3
1.2
%
84.9
90.3
0.43
46
83
(3016228) CD19 cells/100 cells in Blood
238
569
2.15
23.15
2.1
2.0
%
8.9
8.3
0.30
231
558
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
75
90
4.27
22.88
1.1
1.1
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
63
65
4.97
22.58
1.1
1.3
%
31.4
15.8
0.68
12
18
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
259
647
2.06
22.58
1.2
1.1
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
184
398
2.37
22.49
1.1
1.1
u/ml
3.4
7.2
0.74
103
230
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
940
3353
1.44
22.41
1.7
1.4
—
—
—
0
0
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
65
70
4.76
22.31
1.5
1.7
mg/l
3.8
3.8
0.01
40
44
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
65
70
4.76
22.31
1.5
1.7
mg/l
1.0
1.6
0.40
39
45
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
65
70
4.76
22.31
1.5
1.7
mg/l
0.9
0.6
0.29
45
44
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
65
70
4.76
22.31
1.5
1.7
mg/l
2.2
3.8
0.77
43
51
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
65
70
4.76
22.31
1.5
1.7
mg/l
2.2
2.1
0.01
51
50
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
65
70
4.76
22.31
1.5
1.7
mg/l
2.1
1.1
0.87
37
41
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
65
70
4.76
22.31
1.5
1.7
mg/l
1.0
2.2
0.97
50
48
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
65
70
4.76
22.31
1.5
1.7
mg/l
3.0
3.3
0.11
42
43
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
65
70
4.76
22.31
1.5
1.7
mg/l
1.9
2.0
0.04
42
43
(21494814) CD8 cells/100 lymphocytes in Specimen
232
558
2.13
22.26
2.1
2.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
166
345
2.47
22.05
1.1
1.1
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
51
43
6.08
21.98
1.1
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
155
313
2.54
21.81
1.6
1.5
ug/l
8.8
9.1
0.32
155
313
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
289
764
1.94
21.64
1.2
1.1
u/ml
4.5
18.9
1.21
34
70
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
78
105
3.81
20.77
1.0
1.1
u/ml
1.3
3.7
1.05
58
86
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
343
975
1.81
20.67
1.1
1.1
iu/ml
6.5
9.0
0.99
72
287
(3023199) Leukocytes [#/volume] in Pleural fluid
525
1681
1.61
20.63
1.5
1.4
e6/l
2338.3
2724.5
0.39
418
1140
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
62
69
4.61
20.59
2.0
2.0
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
86
126
3.50
20.48
1.1
1.1
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
103
171
3.09
20.43
2.3
1.7
mmol/l
2.8
2.6
0.36
91
154
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
89
134
3.41
20.41
1.1
1.1
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
38
24
8.11
20.28
3.2
1.4
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
87
130
3.43
20.17
9.3
6.8
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
205
490
2.15
20.03
1.1
1.0
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
276
742
1.91
19.75
1.1
1.1
iu/ml
3.4
4.3
0.65
14
64
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
3488
21008
0.84
19.70
1.7
1.7
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
79
112
3.62
19.69
1.0
1.1
u/ml
0.9
11.2
1.55
57
91
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
36
22
8.39
19.63
3.2
1.4
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
65
79
4.22
19.60
2.2
1.6
umol/l
49.6
43.0
0.82
65
79
(44813793)
371
1101
1.73
19.41
1.1
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
78
111
3.60
19.35
1.3
1.1
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
280
764
1.88
19.19
2.0
1.7
u/field
2.2
2.4
0.20
192
605
(3044941) Cell count panel - Synovial fluid
682
2359
1.49
19.08
1.4
1.4
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
48
45
5.47
18.90
10.4
9.7
e6/l
88.1
211.1
1.53
34
30
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
60
71
4.33
18.67
1.1
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
2283
14233
0.81
18.57
1.4
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
609
2070
1.51
18.53
1.6
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
165
372
2.28
18.53
1.3
1.1
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
28
12
11.96
18.52
3.8
1.8
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
78
115
3.48
18.46
1.4
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
304
865
1.81
18.33
1.2
1.2
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
113
212
2.73
18.33
1.1
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
296
836
1.82
18.28
1.7
1.5
u/l
4.3
6.9
2.12
141
421
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
83
129
3.30
18.24
1.0
1.1
—
—
—
0
0
(3036603) Volume of Urine
339
999
1.74
18.21
1.6
1.6
ml
2164.5
1959.5
0.88
87
191
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
61
75
4.17
18.18
3.1
2.7
pmol/l
31.3
54.0
0.21
17
29
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
106
193
2.82
18.13
1.1
1.1
pmol/l
5.5
12.1
0.35
14
26
(3010838) Calcium [Moles/time] in 24 hour Urine
250
671
1.91
18.03
1.7
1.5
mmol/24h
5.5
5.6
0.03
18
43
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
70
97
3.70
18.02
1.0
1.1
u/ml
0.4
5.7
0.61
35
43
(40762814) Titanium [Mass/volume] in Blood
106
194
2.80
17.97
2.2
2.4
ug/l
3.6
4.7
0.52
33
50
(3047352) Trisomy 18 risk [Likelihood] in Fetus
751
5399
0.71
17.96
1.4
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
770
5512
0.71
17.95
1.5
1.5
—
—
—
0
0
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
51
54
4.84
17.88
1.0
1.0
u/ml
0.2
2.2
0.53
41
39
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
616
2116
1.50
17.85
1.4
1.3
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
86
140
3.15
17.65
1.6
1.6
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
84
135
3.19
17.58
1.2
1.0
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
392
1217
1.66
17.48
2.3
2.0
u/field
1.8
2.0
0.22
174
491
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
249
675
1.89
17.46
1.2
1.1
u/l
90.6
83.1
0.48
211
543
(3005033) Fetal Nuchal fold Thickness US
754
5390
0.71
17.44
1.4
1.5
—
—
—
0
0
(3014891) Appearance of Pleural fluid
88
148
3.05
17.18
1.5
1.5
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
669
2357
1.46
17.13
4.2
3.3
u/ml
29.2
40.8
1.69
645
2267
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
82
132
3.19
17.13
1.2
1.0
—
—
—
0
0
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
65
89
3.74
17.01
1.0
1.1
u/ml
0.2
1.1
0.88
33
36
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
247
674
1.88
17.00
1.2
1.1
u/l
28.2
23.4
0.51
199
528
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
933
3498
1.37
16.89
1.6
1.4
pmol/l
130.2
131.2
0.02
906
3430
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
63
86
3.76
16.57
1.2
1.1
nmol/l
15.4
13.3
0.47
22
24
(3020123) Porphyrins [Interpretation] in Serum or Plasma
50
56
4.58
16.56
1.1
1.1
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
46
48
4.91
16.39
2.1
1.7
mmol/l
21.7
21.5
0.01
36
35
(3001964) Herpes simplex virus Ag [Presence] in Specimen
166
399
2.13
16.12
1.8
1.3
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
67
98
3.50
16.09
1.0
1.1
u/ml
0.1
1.2
0.80
36
40
(3020491) Glucose [Moles/volume] in Blood
372
1166
1.64
16.04
1.7
1.9
mmol/l
6.7
6.7
0.05
238
934
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
92
166
2.84
16.04
2.4
2.7
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
471
1564
1.55
16.01
1.5
1.4
e6/l
60390.6
49684.6
0.37
329
862
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
544
1866
1.50
15.94
1.4
1.3
—
—
—
0
0
(4034850)
1058
7089
0.76
15.90
11.6
8.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
207
545
1.95
15.84
1.2
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
194
499
2.00
15.84
1.6
1.7
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
62
87
3.65
15.75
2.7
1.6
umol/l
1.3
1.3
0.40
55
73
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
87
155
2.88
15.51
2.3
2.1
mmol/l
1.1
1.6
1.09
51
123
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
252
714
1.81
15.50
1.0
1.1
%
98.1
95.9
0.52
217
549
(3007463) Buprenorphine [Presence] in Urine
46
51
4.62
15.42
5.4
12.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
1011
3896
1.34
15.38
1.3
1.3
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
31
22
7.22
15.32
1.7
1.3
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
626
2227
1.45
15.31
1.1
1.0
u/ml
0.3
0.6
1.12
191
411
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
3242
19250
0.85
15.27
3.5
3.2
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
187
482
1.99
15.20
1.2
1.1
g/l
0.8
0.2
—
6
32
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
288
858
1.72
15.01
6.4
7.2
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
56
76
3.78
14.88
1.1
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
368
1174
1.61
14.85
1.1
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
740
2732
1.39
14.76
1.1
1.0
u/ml
5.4
4.7
0.22
340
1031
(3019897) Erythrocyte distribution width [Ratio] by Automated count
388
3037
0.65
14.73
2.7
2.2
%
13.1
13.1
0.30
381
2991
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
246
705
1.79
14.62
6.7
4.5
u/ml
813.9
1496.1
0.29
54
101
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
1219
4858
1.29
14.61
1.9
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
6062
27938
1.13
14.60
1.5
1.4
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
84
154
2.80
14.30
1.1
1.2
u/ml
0.0
0.6
1.29
54
87
(3003434) Protein [Mass/volume] in Pleural fluid
546
1920
1.46
14.22
1.5
1.4
g/l
32.0
33.6
1.96
492
1728
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
155
382
2.08
14.21
1.1
1.1
—
—
—
0
0
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
60
90
3.42
13.97
1.4
1.3
ml/s/173m2
1.0
1.2
0.88
47
54
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
146
357
2.10
13.68
1.1
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
88
170
2.65
13.67
2.3
1.6
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
68
113
3.08
13.63
1.1
1.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
201
554
1.86
13.55
2.7
2.4
au/ml
166.9
144.7
0.20
30
77
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
151
378
2.05
13.34
2.6
1.9
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
77
140
2.82
13.33
2.2
2.9
u/field
0.6
0.5
0.43
77
140
(3023487) Leukocytes [#/volume] in Peritoneal fluid
175
463
1.94
13.31
2.7
1.6
e6/l
788.1
4502.4
0.92
135
285
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
97
201
2.47
13.18
1.1
1.1
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
216
615
1.80
13.17
3.3
2.9
mg/l
7.8
8.5
0.67
181
462
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
23
13
9.06
13.17
4.7
1.5
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
193
531
1.86
13.10
2.0
2.3
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
138
336
2.11
13.09
1.1
1.1
mg/g
6.5
6.1
0.28
131
323
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
247
734
1.73
13.07
1.1
1.3
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
96
199
2.47
13.04
1.9
1.4
—
—
—
0
0
(3019920) Amitriptyline [Moles/volume] in Serum or Plasma
27
20
6.92
12.95
1.7
1.5
nmol/l
346.1
174.9
0.60
20
15
(3013336) Amino acids [Identifier] in Serum or Plasma
30
26
5.91
12.73
2.5
2.1
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
35
36
4.98
12.71
1.4
1.4
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
72
130
2.84
12.64
1.3
1.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
1064
4253
1.29
12.53
6.1
5.0
mmol/l
1.4
1.3
1.11
943
3652
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
38
43
4.53
12.52
1.5
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
215
623
1.77
12.42
1.8
1.9
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
152
393
1.98
12.36
1.8
1.7
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
67
118
2.91
12.27
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
746
2845
1.35
12.27
1.2
1.2
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
64
110
2.98
12.20
1.2
1.2
umol/24h
2.0
1.7
0.66
64
110
(3001686) Cold agglutinin [Titer] in Serum or Plasma
99
218
2.33
11.91
1.3
1.2
titre
80.1
268.1
0.93
11
22
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
49
72
3.49
11.80
1.0
1.1
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
191
543
1.80
11.77
2.2
1.8
mg/l
9.3
9.5
0.20
160
411
(3017509) Phencyclidine [Presence] in Urine
94
204
2.36
11.67
2.4
1.5
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
256
794
1.65
11.66
1.1
1.1
iu/ml
197.9
216.7
0.26
256
784
(3012920) Ethanol [Mass/volume] in Serum or Plasma
20
11
9.32
11.63
1.4
1.1
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
32
33
4.97
11.61
1.1
1.5
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
140
363
1.98
11.35
1.3
1.2
ug/l
221.1
185.3
0.08
80
185
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
160
435
1.89
11.33
1.3
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
224
677
1.70
11.25
3.7
3.1
—
—
—
0
0
(3033942) Copper [Moles/time] in 24 hour Urine
39
50
4.00
11.20
1.3
1.1
umol/24h
1.4
0.4
0.77
19
20
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
105
246
2.19
11.02
1.6
1.3
%
20.3
22.1
0.25
90
203
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
76
154
2.53
10.88
1.3
1.2
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
682
4591
0.76
10.75
4.5
3.6
kpa
5.0
5.0
0.09
670
4491
(3012501) Base excess in Blood by calculation
682
4591
0.76
10.75
4.4
3.6
mmol/l
2.3
2.5
0.61
445
3087
(3026692) Albumin [Mass/volume] in Peritoneal fluid
132
342
1.98
10.75
1.6
1.2
g/l
15.4
13.4
1.38
108
257
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
72
143
2.58
10.72
3.3
2.5
mg/l
1.5
1.3
0.15
46
94
(3012441) Differential panel - Pleural fluid
437
1560
1.44
10.67
1.5
1.4
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
155
427
1.86
10.59
2.5
1.5
e6/l
21859.2
10228.6
0.46
94
201
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
25
22
5.82
10.50
2.8
3.2
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
39
53
3.77
10.44
1.5
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
1222
7643
0.81
10.34
1.7
1.8
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
154
429
1.84
10.19
1.8
1.6
au/ml
100.9
132.7
0.33
16
50
(3049233) Organic acids panel - Urine
19
12
8.11
10.18
1.1
1.0
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
691
4603
0.77
10.10
4.5
3.7
kpa
8.9
8.7
2.42
679
4503
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
109
270
2.07
10.03
1.5
1.4
nmol/l
5.3
5.9
1.03
104
261
(3006442) Creatine [Moles/volume] in Serum or Plasma
350
1213
1.48
9.98
1.6
1.4
umol/l
68.9
72.4
0.42
24
108
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
44
68
3.32
9.93
1.1
1.4
%
46.3
35.6
0.65
24
58
(3012898) Urea [Moles/volume] in Urine
65
128
2.60
9.87
1.3
1.5
mmol/l
178.0
172.3
0.10
59
108
(3023430) Cat dander IgE Ab [Units/volume] in Serum
672
2615
1.32
9.76
1.1
1.0
u/ml
5.5
5.8
0.13
326
1051
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
361
1266
1.46
9.72
1.4
1.3
u/l
408.0
510.7
0.99
349
1200
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
437
3092
0.72
9.72
1.2
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
613
2356
1.34
9.70
1.5
1.4
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
113
288
2.01
9.67
1.7
1.3
g/l
40.2
47.2
0.12
88
231
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
360
1264
1.46
9.64
2.0
1.7
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
255
831
1.57
9.64
1.9
2.0
ug/l
4.0
3.6
0.21
225
741
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
80
178
2.30
9.51
2.8
2.4
pmol/l
68.5
70.4
0.05
73
158
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
27
29
4.77
9.45
1.0
1.0
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
267
884
1.55
9.44
1.4
1.2
u/l
223.7
389.5
2.33
237
837
(3051387) C reactive protein [Mass/volume] in Capillary blood
682
4501
0.77
9.32
4.3
3.0
mg/l
25.8
27.5
0.55
374
2961
(3011335) Digoxin [Mass/volume] in Serum or Plasma
45
74
3.12
9.29
2.2
2.1
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
250
819
1.57
9.26
2.0
2.1
ug/l
2.3
2.3
0.01
201
711
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
470
1746
1.38
9.25
1.5
1.3
pmol/l
65.8
138.2
0.76
198
491
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
208
652
1.64
9.22
1.2
1.3
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
62
124
2.56
9.17
3.5
2.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
109
280
2.00
9.16
1.2
1.2
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
302
1037
1.49
9.06
1.2
1.1
—
—
—
0
0
(4133840)
161
473
1.75
9.04
1.2
1.2
—
—
—
0
0
(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid
40
62
3.31
9.02
1.2
1.4
%
16.8
14.2
0.18
25
55
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
32
42
3.90
8.99
9.5
8.3
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
29
35
4.25
8.98
1.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
115
305
1.93
8.87
1.2
1.1
—
—
—
0
0
(3018001) Oat IgE Ab [Units/volume] in Serum
44
74
3.05
8.79
1.0
1.0
u/ml
0.4
0.3
0.05
16
24
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
38
58
3.36
8.77
1.4
1.6
nmol/l
31.3
17.4
1.04
38
58
(40757373) Influenza virus identified in Isolate
88
212
2.13
8.74
1.8
1.4
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
156
459
1.74
8.73
1.2
1.2
%
20.2
20.9
0.03
17
82
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
115
307
1.92
8.71
1.2
1.1
—
—
—
0
0
(3013862) HLA-DP [Type]
29
36
4.13
8.71
1.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
102
261
2.00
8.69
1.6
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
546
2101
1.33
8.63
3.0
2.3
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
73
164
2.28
8.54
3.4
2.8
umol/l
38.9
45.8
1.43
63
144
(3025549) Creatine [Moles/time] in 24 hour Urine
50
93
2.76
8.48
1.4
1.4
—
14.3
—
0
5
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
26
30
4.44
8.47
7.8
9.0
—
—
—
0
0
(3049242) von Willebrand panel - Platelet poor plasma
26
30
4.44
8.47
1.5
1.9
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
114
307
1.90
8.44
1.2
1.1
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
29
37
4.02
8.44
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
29
37
4.02
8.44
1.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
29
37
4.02
8.44
1.0
1.0
—
—
—
0
0
(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum
37
57
3.33
8.44
1.1
1.1
u/ml
19.9
22.3
0.08
26
44
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
113
304
1.91
8.39
1.2
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
97
247
2.01
8.39
1.4
1.3
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
209
673
1.59
8.38
1.3
1.2
%
73.8
67.6
0.35
18
86
(3020650) Glucose [Presence] in Urine
61
668
0.47
8.12
1.6
1.3
—
—
—
0
0
(3042951) Complement C1q Ab [Units/volume] in Serum
36
56
3.29
8.11
1.1
1.4
u/ml
18.9
23.6
—
8
13
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
45
81
2.85
8.09
1.4
1.4
—
—
—
0
0
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
49
93
2.70
8.04
1.0
1.0
u/ml
0.2
0.8
0.60
34
63
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
42
74
2.91
7.83
1.0
1.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
9567
46273
1.07
7.81
4.7
3.3
estimate
0.0
0.0
1.16
3064
16347
(3002621) Streptococcal DNAse B [Units/volume] in Serum
58
123
2.42
7.71
1.1
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
486
1875
1.33
7.62
1.7
1.5
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
69
160
2.21
7.57
1.3
1.2
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
21
22
4.89
7.57
1.2
2.5
mu/l
2.8
1.6
0.49
21
22
(3029612) Listeria sp Ab [Titer] in Serum
20
20
5.12
7.53
1.5
1.2
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
287
1017
1.45
7.46
1.3
1.3
u/l
13.7
14.4
0.19
262
958
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
165
518
1.63
7.38
1.2
1.1
—
—
—
0
0
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
28
39
3.68
7.35
1.2
1.0
pmol/l
333.9
222.1
0.52
16
21
(3036071) Salmonella sp Ab [Titer] in Serum
168
531
1.62
7.32
1.1
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
144
439
1.68
7.21
2.6
1.7
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
54
115
2.41
7.15
1.1
1.1
—
—
—
0
0
(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid
34
56
3.11
7.08
1.1
1.3
%
1.2
1.0
0.08
19
49
(40768800) Prostate Pathology biopsy report
818
3418
1.23
6.83
1.2
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
925
3915
1.21
6.81
2.1
2.2
g/l
132.3
131.3
0.51
616
3054
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
25
34
3.77
6.78
1.0
1.1
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
470
3107
0.77
6.65
2.3
1.7
mmol/l
1.7
1.8
0.54
460
3034
(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid
21
25
4.30
6.65
6.9
10.6
%
43.8
43.3
—
8
16
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
115
339
1.74
6.53
1.3
1.2
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
116
343
1.73
6.51
1.3
1.3
%
38.7
38.4
0.02
75
249
(3045462) Protein/Creatinine [Ratio] in Urine
59
137
2.21
6.51
4.5
6.8
g/mol
56.0
66.6
0.18
52
130
(40768806) Pleura Pathology biopsy report
409
1579
1.33
6.46
1.6
1.5
—
—
—
0
0
(40758047) Lysozyme [Mass/volume] in Pleural fluid
57
132
2.21
6.34
1.2
1.1
mg/l
9.1
8.9
0.07
52
124
(3050794) Legionella sp Ab [Presence] in Serum
55
126
2.24
6.27
1.1
1.1
—
—
—
0
0
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
54
124
2.23
6.14
1.4
1.2
mg/l
55.8
46.6
0.51
17
38
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
95
270
1.80
6.11
4.5
5.0
u/l
48.2
53.7
0.16
32
108
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
1054
6350
0.85
6.10
1.6
1.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
359
1375
1.34
6.02
1.5
1.5
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
26
40
3.33
6.02
1.0
1.1
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
25
38
3.37
5.89
1.9
2.4
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
23
33
3.57
5.86
1.0
1.0
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
13
7
9.51
5.84
1.0
1.0
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
63
158
2.04
5.81
1.5
1.5
—
—
—
0
0
(1002224) Polysomnography panel
1764
7978
1.14
5.79
1.1
1.1
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
35
67
2.68
5.75
2.1
1.4
umol/l
0.6
0.7
0.18
26
50
(3044242) Glucose [Moles/volume] in Arterial blood
181
620
1.50
5.70
1.9
2.1
—
—
—
0
0
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
38
77
2.53
5.63
1.2
1.3
pmol/l
17.2
16.4
0.10
28
69
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
67
175
1.96
5.57
11.2
7.1
umol/l
0.4
0.3
0.88
58
156
(3028717) Thiamine [Mass/volume] in Blood
51
120
2.18
5.52
1.2
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
320
1222
1.34
5.52
2.5
2.0
ml
664.9
698.5
0.72
251
749
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
174
598
1.49
5.41
1.1
1.1
—
—
—
0
0
(3010421) pH of Blood
848
5141
0.84
5.34
4.2
3.6
ph
7.4
7.4
1.31
670
4496
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
169
579
1.50
5.34
1.1
1.1
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
34
67
2.60
5.33
1.1
1.1
u/l
2.3
4.4
—
8
17
(3013945) Hepatitis B virus e Ab [Presence] in Serum
40
86
2.38
5.29
1.5
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
690
2917
1.21
5.26
3.7
2.8
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
51
123
2.12
5.23
1.3
1.1
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
43
97
2.27
5.14
1.3
1.2
umol/24h
294.7
316.3
0.32
43
97
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
62
163
1.95
5.09
1.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
100
306
1.68
5.08
2.0
2.7
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
207
747
1.42
5.05
4.3
2.5
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
32
63
2.60
5.04
2.0
1.6
ng/l
214.4
190.9
0.57
24
57
(3022689) Creatine [Moles/volume] in Urine
102
315
1.66
5.01
1.5
1.4
—
—
—
0
0
(3003633) Ovomucoid IgE Ab [Units/volume] in Serum
42
95
2.27
5.00
1.2
1.6
u/ml
1.0
9.1
0.65
37
76
(3032641) Amino acids panel - Urine
14
15
4.78
4.97
1.1
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
182
644
1.45
4.94
4.7
3.6
—
—
—
0
0
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
39
86
2.32
4.92
1.1
1.1
u/ml
8.9
8.7
0.02
24
47
(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid
29
55
2.70
4.89
1.1
1.1
mg/l
0.0
0.8
0.52
24
49
(4211845)
221
817
1.39
4.74
4.1
2.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
213
1492
0.73
4.71
1.6
1.4
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
69
194
1.82
4.69
1.7
1.5
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
26
48
2.78
4.61
1.4
1.3
nmol/l
497.6
530.1
0.08
26
48
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
61
166
1.88
4.58
3.1
2.5
mg/l
21.5
23.2
0.44
56
156
(40762887) Creatinine [Moles/volume] in Blood
16
21
3.90
4.58
1.2
1.2
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
35
76
2.36
4.58
1.5
1.4
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
60
163
1.89
4.54
3.1
2.5
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
146
504
1.49
4.53
1.9
1.9
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
45
110
2.10
4.51
1.1
1.1
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
38
87
2.24
4.45
1.1
1.0
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
42
101
2.13
4.39
1.1
1.1
u/l
9.8
12.2
0.33
42
101
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
35
78
2.30
4.35
1.2
1.1
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
43
105
2.10
4.34
1.5
1.4
pmol/l
8.4
20.9
1.64
36
94
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
34
75
2.32
4.32
1.2
1.0
u/l
91.2
50.9
0.46
26
60
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
26
50
2.66
4.31
1.0
1.1
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
39
92
2.17
4.28
1.6
1.4
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
147
1071
0.70
4.19
1.6
1.4
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
75
226
1.70
4.11
1.1
1.0
ug/l
84.8
78.8
0.54
59
191
(21494567) Legionella sp IgM Ab [Presence] in Serum
45
115
2.01
4.07
1.1
1.1
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
121
412
1.51
4.05
1.4
1.2
mmol/l
3.3
3.7
0.60
109
380
(3018738) Hemoglobin F/Hemoglobin.total in Blood
42
105
2.05
4.02
3.7
2.1
%
12.0
14.7
0.28
17
29
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
1064
6192
0.88
3.99
1.4
1.4
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
121
414
1.50
3.97
2.8
1.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
910
4048
1.15
3.94
3.7
3.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
4381
21105
1.07
3.93
1.7
1.8
—
—
—
0
0
(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum
12
14
4.39
3.92
1.0
1.1
—
—
—
0
0
(3020911) Cortisol [Moles/time] in 24 hour Urine
16
24
3.42
3.90
1.1
1.2
nmol/24h
117.2
87.7
0.62
16
24
(40761995) Spermatozoa Progressive [#/volume] in Semen
90
707
0.65
3.85
2.6
3.2
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
90
707
0.65
3.85
5.2
6.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
680
4075
0.85
3.85
2.9
2.3
%
16.7
16.6
0.36
403
1928
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
150
1071
0.72
3.84
1.5
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
307
1233
1.28
3.83
1.9
1.7
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
59
170
1.78
3.79
1.7
1.6
ug/l
110.1
111.9
0.04
48
138
(3025315) Body weight
46
122
1.93
3.79
4.4
3.9
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
49
133
1.89
3.78
1.2
1.1
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
32
74
2.22
3.71
1.1
1.1
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
38
95
2.05
3.67
1.0
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
162
1133
0.73
3.66
1.2
1.3
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
30
68
2.26
3.64
3.6
3.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
228
887
1.32
3.63
1.3
1.4
mmol/l
5.7
5.6
0.86
210
838
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
25
52
2.46
3.62
1.0
1.1
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
19
34
2.86
3.59
1.0
1.1
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
20
37
2.77
3.58
1.0
1.0
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
46
125
1.89
3.56
1.4
1.3
u/l
647.3
73.2
0.44
35
90
(40759632) Porphyrins [Mass/mass] in Stool
10
9
5.69
3.53
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
4425
21403
1.06
3.53
1.5
1.4
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
75
237
1.62
3.51
2.0
3.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
651
3879
0.86
3.47
1.7
1.6
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
20
38
2.70
3.43
1.1
1.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
34
84
2.07
3.40
1.1
1.2
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
348
1442
1.24
3.39
1.4
1.3
mmol/l
6.3
6.1
0.68
321
1332
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
25
54
2.37
3.38
1.1
1.1
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
108
376
1.47
3.33
2.4
2.2
ng/l
154.8
95.9
0.89
67
176
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
2198
12161
0.92
3.18
1.6
1.5
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
78
256
1.56
3.17
1.6
1.3
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
32
80
2.05
3.13
1.0
1.0
—
—
—
0
0
(3016031) Almond IgE Ab [Units/volume] in Serum
37
98
1.93
3.11
1.1
1.1
u/ml
1.0
1.1
0.07
22
65
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
13
20
3.33
3.09
6.6
3.4
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
26
60
2.22
3.08
16.4
3.8
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
32
81
2.02
3.04
1.1
1.1
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
292
1203
1.24
3.04
1.1
1.1
u/ml
1.1
2.0
0.44
103
327
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
21
44
2.44
3.04
1.0
1.1
nmol/l
267.8
265.3
0.02
21
44
(3007919) Fasciola sp Ab [Titer] in Serum
14
23
3.12
3.04
1.0
1.1
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
15
26
2.96
3.01
1.2
1.1
%
3.7
2.4
0.56
15
26
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
33
85
1.99
3.00
1.1
1.0
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
67
216
1.59
2.95
1.7
1.5
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
12
18
3.41
2.95
2.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
12
18
3.41
2.95
1.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
12
18
3.41
2.95
2.0
2.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
12
18
3.41
2.95
1.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
12
18
3.41
2.95
2.0
2.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
12
18
3.41
2.95
1.0
1.0
—
—
—
0
0
(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
7
5
7.17
2.94
1.0
1.2
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
33
86
1.97
2.92
1.2
1.1
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
866
4993
0.89
2.91
1.5
1.5
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
64
205
1.60
2.90
1.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
1164
6596
0.90
2.88
1.4
1.5
—
—
—
0
0
(3035880) pH of Pleural fluid
202
802
1.29
2.87
1.3
1.2
—
—
—
0
0
(3035510) Gentamicin [Mass/volume] in Serum or Plasma
18
36
2.56
2.85
6.4
5.4
mg/l
1.0
1.7
—
10
31
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
989
5650
0.89
2.85
1.8
1.8
—
—
—
0
0
(3027540) Rickettsia typhi Ab [Titer] in Serum
15
27
2.85
2.84
1.1
1.1
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
22
49
2.30
2.83
1.1
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
67
219
1.57
2.81
1.1
1.0
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
40
347
0.59
2.75
3.1
3.0
ml/dl
14.8
14.8
0.04
34
330
(3007700) Barley IgE Ab [Units/volume] in Serum
25
60
2.13
2.73
1.0
1.0
u/ml
0.9
0.2
—
10
29
(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
25
60
2.13
2.73
1.9
1.5
u/l
0.1
0.3
—
7
18
(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline
8
8
5.12
2.73
1.6
1.0
nmol/l
296.1
271.4
—
8
8
(3002619) Bacteria identified in Specimen by Culture
88
308
1.46
2.72
1.3
1.2
—
—
—
0
0
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
13
22
3.03
2.72
1.1
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
44
130
1.73
2.70
1.1
1.0
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
39
111
1.80
2.70
1.0
1.1
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
36
101
1.83
2.62
1.3
1.3
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
55
176
1.60
2.55
1.8
1.7
mg/l
1.7
1.8
0.25
49
144
(3034614) HLA Ag [Interpretation]
14
26
2.76
2.54
1.2
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
37
106
1.79
2.53
1.4
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
278
1727
0.82
2.53
1.5
1.5
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
36
103
1.79
2.48
1.0
1.0
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
27
70
1.98
2.47
1.2
1.1
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
15
30
2.56
2.40
1.7
1.2
mmol/24h
1.6
2.1
0.68
15
30
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
1106
6218
0.91
2.40
1.4
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
547
2444
1.15
2.40
1.3
1.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
1105
6212
0.91
2.39
1.4
1.5
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
28
75
1.91
2.35
1.2
1.1
—
610.0
—
0
5
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
1101
6180
0.91
2.32
1.4
1.4
—
—
—
0
0
(3007542) Rye IgE Ab [Units/volume] in Serum
27
72
1.92
2.30
1.0
1.0
u/ml
1.1
0.2
—
9
32
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
1106
6203
0.91
2.30
1.4
1.4
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
46
146
1.61
2.24
1.0
1.0
—
—
—
0
0
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
7
8
4.48
2.23
1.3
1.5
—
—
—
0
0
(3016750) Collection duration of Urine
213
882
1.24
2.23
2.2
1.9
min
494.2
501.8
0.60
192
592
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
203
837
1.24
2.21
1.9
1.8
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
360
2155
0.85
2.19
2.2
2.2
pg
32.9
32.7
0.33
355
2138
(3007147) Virus identified in Stool by Electron microscopy
6
6
5.12
2.14
1.0
1.0
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
6
6
5.12
2.14
1.5
1.2
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
46
148
1.59
2.14
1.2
1.1
u/l
21.9
19.6
0.36
29
100
(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
14
29
2.47
2.12
1.1
1.0
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
279
1199
1.19
2.05
1.1
1.1
u/ml
1.5
4.1
0.58
84
283
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
7
9
3.98
2.05
1.4
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
557
2526
1.13
2.02
1.7
1.7
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
709
3262
1.11
2.01
1.1
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
139
555
1.28
2.01
1.2
1.1
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
21
54
1.99
2.00
1.1
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
109
422
1.32
1.98
1.2
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
708
3263
1.11
1.96
1.1
1.1
—
—
—
0
0
(3024316) Viscosity of Plasma
27
77
1.80
1.93
1.3
1.8
mpas
1.7
1.9
0.83
13
40
(3036312) Salmon IgE Ab [Units/volume] in Serum
27
77
1.80
1.93
1.0
1.1
u/ml
0.0
3.9
2.17
20
52
(3002814) Trichinella spiralis Ab [Titer] in Serum
8
13
3.15
1.86
1.0
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
71
260
1.40
1.84
1.3
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
166
688
1.24
1.80
1.0
1.0
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
113
447
1.30
1.79
1.3
1.3
%
48.5
56.4
1.40
97
385
(3032868) Hemoglobin electrophoresis panel in Blood
47
160
1.50
1.77
1.6
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
190
1171
0.83
1.71
1.5
1.4
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
122
491
1.27
1.71
6.8
5.5
mmol/l
24.4
25.1
1.05
114
433
(3000034) Microalbumin [Mass/volume] in Urine
233
1006
1.19
1.69
3.0
2.8
mg/l
59.0
56.4
0.05
159
703
(3046861) Legionella sp Ag [Presence] in Urine
11
119
0.47
1.68
1.0
1.1
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
57
205
1.42
1.66
2.9
2.5
—
—
—
0
0
(3008343) Lysozyme [Mass/volume] in Urine
5
6
4.27
1.65
1.0
1.0
mg/l
0.5
22.8
—
5
6
(3039000) Anion gap in Blood
648
3009
1.10
1.62
8.0
5.8
mmol/l
11.5
11.3
0.53
585
2671
(3018572) Chloride [Moles/volume] in Blood
648
3010
1.10
1.61
8.0
5.8
mmol/l
105.1
105.1
0.03
586
2672
(40758358) Immune stain study
18
48
1.92
1.60
1.0
1.0
—
—
—
0
0
(44806420)
73
495
0.75
1.55
2.5
2.3
—
—
—
0
0
(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum
17
45
1.94
1.54
1.1
1.0
u/ml
0.7
0.4
—
6
15
(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum
15
38
2.02
1.52
1.1
1.0
u/ml
0.9
0.5
—
6
15
(3012565) Volume of 24 hour Urine
158
975
0.83
1.49
2.0
2.3
ml
2009.6
2005.3
0.01
146
887
(3044590) Delta aminolevulinate [Moles/volume] in Urine
5
7
3.66
1.47
1.0
1.1
umol/l
15.2
22.1
—
5
7
(3027696) Helicobacter pylori Ab [Titer] in Serum
6
10
3.07
1.46
1.0
1.0
titre
900.0
1547.0
—
6
10
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
269
1193
1.16
1.45
1.2
1.1
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
637
2975
1.10
1.45
1.3
1.3
ug/l
3.4
4.0
0.71
561
2706
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
24
73
1.68
1.45
1.2
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
232
1019
1.17
1.43
1.2
1.2
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
23
70
1.68
1.39
1.2
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
98
396
1.27
1.39
1.1
1.1
u/ml
66.1
62.0
0.19
98
384
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
6
11
2.79
1.33
1.0
1.0
—
—
—
0
0
(3003095) Rheumatoid factor [Units/volume] in Synovial fluid
5
8
3.20
1.32
1.0
1.0
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
5
62
0.41
1.32
1.0
1.0
g/l
181.0
166.1
—
5
62
(3038071) Oxygen [Partial pressure] in Mixed venous blood
71
277
1.31
1.32
11.6
6.1
—
—
—
0
0
(3004268) Protein electrophoresis panel - Cerebral spinal fluid
10
23
2.23
1.28
1.5
1.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
146
624
1.20
1.26
2.7
3.0
—
—
—
0
0
(3015665) Acarus siro IgE Ab [Units/volume] in Serum
16
45
1.82
1.26
1.0
1.0
u/ml
0.9
0.4
—
6
14
(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method
5
9
2.85
1.19
1.0
1.0
—
—
—
0
0
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
10
24
2.13
1.17
2.3
2.2
—
—
—
0
0
(3015350) Toxocara sp Ab [Presence] in Serum
7
14
2.56
1.17
1.0
1.0
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
155
672
1.18
1.17
2.0
2.2
ug/min
102.8
124.4
0.14
41
136
(3000285) Sodium [Moles/volume] in Blood
46
172
1.37
1.16
1.2
1.1
—
—
—
0
0
(3020618) Glucose [Moles/volume] in Synovial fluid
14
39
1.84
1.14
1.1
1.1
mmol/l
5.4
4.9
0.21
14
29
(3003577) Lead [Moles/volume] in Blood
42
155
1.39
1.14
1.1
1.6
umol/l
0.1
0.2
1.98
11
65
(1617658) Protocol used for examination of sentinel lymph nodes
207
1215
0.87
1.13
1.0
1.0
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
7
15
2.39
1.13
1.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
822
3934
1.07
1.11
1.7
1.6
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
66
263
1.29
1.10
1.3
1.8
ug/l
2.7
4.4
0.43
37
173
(3021162) Amylase [Enzymatic activity/volume] in Specimen
61
241
1.30
1.09
2.7
2.9
u/l
1841.2
1622.7
0.08
54
221
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
5
10
2.56
1.08
1.2
1.0
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
27
94
1.47
1.01
1.0
1.2
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
6
12
2.56
1.00
2.7
2.0
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
176
1032
0.87
0.98
1.6
1.4
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
540
2567
1.08
0.92
1.3
1.3
mmol/l
7.1
7.0
0.55
395
1832
(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma
6
14
2.20
0.91
1.0
1.3
ng/l
40.7
20.2
—
6
8
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
12
35
1.76
0.88
1.7
1.2
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
29
106
1.40
0.88
5.1
4.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
101
436
1.19
0.87
1.2
1.2
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
8
22
1.86
0.87
1.1
1.4
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
58
237
1.25
0.85
1.0
1.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
8749
45492
0.98
0.82
1.7
1.6
mmol/l
1.4
1.4
10.65
7768
37319
(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay
23
82
1.44
0.80
1.4
1.3
mg/l
1.9
1.5
0.74
18
68
(3010937) Rubella virus Ab [Presence] in Serum
31
117
1.36
0.80
1.0
1.1
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
31
117
1.36
0.80
1.3
1.2
ug/l
91.5
111.4
0.38
19
76
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
41
269
0.78
0.80
4.1
4.8
ug/min
42.8
50.5
0.41
26
220
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
22
78
1.44
0.79
3.0
1.4
—
—
—
0
0
(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid
5
11
2.33
0.79
1.0
1.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
9890
49963
1.02
0.78
3.7
2.8
—
—
—
0
0
(3000012) Reticulocyte production index
169
974
0.89
0.78
1.3
1.6
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
378
1789
1.08
0.77
1.3
1.4
mmol/l
11.6
11.7
0.10
123
291
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
78
334
1.20
0.76
11.0
6.4
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
242
1123
1.10
0.76
1.0
1.0
u/ml
0.6
0.5
0.09
35
140
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
7
19
1.89
0.75
1.1
1.0
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
2684
14133
0.97
0.75
4.1
3.7
mmol/l
1.2
1.2
0.40
2469
12046
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
235
1326
0.91
0.74
1.3
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
72
307
1.20
0.74
1.1
1.1
—
—
—
0
0
(3042934) Triiodothyronine (T3) Ab [Presence] in Serum
7
20
1.79
0.72
1.1
1.1
—
—
—
0
0
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
16
119
0.69
0.71
1.4
1.1
u/field
1.1
1.2
0.24
11
76
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
14
47
1.53
0.66
1.1
1.0
mmol/l
—
—
—
0
0
(36304079) Mucus [Presence] in Urine sediment
0
11
0.00
0.64
0.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
126
571
1.13
0.63
1.5
1.9
—
—
—
0
0
(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field
19
69
1.41
0.63
1.1
1.5
u/field
1.2
1.1
—
10
41
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
122
552
1.13
0.63
1.0
1.0
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
8
25
1.64
0.63
1.3
1.0
—
—
—
0
0
(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum
0
12
0.00
0.63
0.0
1.1
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
121
548
1.13
0.62
1.4
1.4
%
54.5
62.9
1.72
97
462
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
27
105
1.32
0.61
1.1
1.5
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
55
336
0.84
0.60
5.0
5.9
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
370
1775
1.07
0.58
1.2
1.2
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
10
78
0.66
0.58
1.2
1.0
—
—
—
0
0
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
6
18
1.71
0.58
1.3
1.0
—
—
—
0
0
(4038314)
42
175
1.23
0.57
1.2
1.1
—
—
—
0
0
(3022670) pH of Venous cord blood
14
49
1.46
0.56
1.0
1.0
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
56
243
1.18
0.53
2.0
2.1
mmol/l
7.1
7.0
0.12
21
87
(3035611) Eosinophils/100 leukocytes in Synovial fluid
19
129
0.75
0.53
1.2
1.7
%
1.0
0.6
0.21
14
101
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
11
37
1.52
0.52
4.2
5.8
mmol/l
0.2
0.2
0.43
11
37
(3036525) Urea [Moles/time] in 24 hour Urine
27
109
1.27
0.49
2.2
3.0
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
12
42
1.46
0.49
1.1
1.1
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
45
193
1.19
0.49
1.4
1.4
%
31.4
23.7
0.71
37
146
(3004451) EKG impression Narrative
149
835
0.91
0.48
1.3
1.2
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
13
92
0.72
0.48
1.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
47
283
0.85
0.47
1.2
1.2
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
15
56
1.37
0.45
1.1
1.1
mmol/l
8.1
8.8
0.55
15
56
(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum
0
10
0.00
0.42
0.0
1.1
—
—
—
0
0
(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum
0
10
0.00
0.42
0.0
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
323
1574
1.05
0.36
1.6
1.5
%
34.5
31.7
0.64
211
971
(3017937) Magnesium [Moles/time] in 24 hour Urine
12
45
1.37
0.36
1.1
1.2
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
6
22
1.40
0.35
1.0
1.0
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
151
720
1.07
0.35
1.1
1.1
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
93
521
0.91
0.34
1.3
1.4
%
3.1
2.5
0.35
78
444
(3003157) Bacteria [#/volume] in Mother's milk
10
37
1.38
0.33
2.9
6.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
711
3539
1.03
0.30
1.3
1.3
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
28
122
1.18
0.29
1.0
1.0
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
339
1670
1.04
0.27
1.5
1.6
mmol/l
8.1
7.5
3.48
233
939
(3001019) Free T4 and TSH panel - Serum or Plasma
2170
10964
1.01
0.25
1.7
1.6
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
6
44
0.70
0.25
1.2
1.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
255
1253
1.04
0.24
2.9
2.1
—
—
—
0
0
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
5
19
1.35
0.24
1.2
1.2
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
5
19
1.35
0.24
1.2
1.2
—
—
—
0
0
(3019977) pH of Arterial blood
186
909
1.05
0.23
2.5
2.4
ph
7.4
7.4
0.13
52
374
(3013762) Body weight Measured
12
49
1.25
0.23
1.1
1.2
—
—
—
0
0
(3027114) Cholesterol [Mass/volume] in Serum or Plasma
0
6
0.00
0.22
0.0
1.0
—
—
—
0
0
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
24
141
0.87
0.22
4.3
2.0
%
14.8
19.7
0.48
18
62
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
44
248
0.91
0.21
1.5
1.4
%
8.7
10.4
0.25
21
142
(3034891) Synovial lining cells/100 cells in Synovial fluid
157
843
0.95
0.21
1.7
1.4
%
4.9
4.1
0.19
32
215
(3005082) Progesterone [Moles/volume] in Serum or Plasma
226
1203
0.96
0.21
1.4
1.4
nmol/l
26.8
33.0
2.71
201
1126
(3002079) Sodium [Moles/time] in 24 hour Urine
6
25
1.23
0.20
1.3
1.0
mmol/24h
108.1
158.2
—
6
25
(3021691) Plasmodium malariae Ab [Titer] in Serum
6
26
1.18
0.20
3.3
2.3
—
—
—
0
0
(3001729) Color of Synovial fluid
25
145
0.88
0.20
1.2
1.6
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
7
29
1.24
0.19
1.1
1.1
—
—
—
0
0
(3021706) Oxygen [Partial pressure] in Arterial cord blood
27
154
0.90
0.17
1.0
1.0
kpa
2.6
3.6
2.03
21
131
(3019298) Eosinophils/100 leukocytes in Peritoneal fluid
6
39
0.79
0.16
1.3
1.2
%
0.0
0.6
—
6
32
(4281824)
353
1852
0.98
0.16
1.3
1.1
—
—
—
0
0
(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum
9
40
1.15
0.16
1.3
1.1
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
72
349
1.06
0.14
1.7
2.7
mmol/l
8.2
7.2
0.85
56
176
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
63
307
1.05
0.11
1.3
1.1
mg/l
76.8
34.5
0.23
42
225
(3041918) Cholesterol [Moles/volume] in Pleural fluid
53
257
1.06
0.11
1.3
1.2
mmol/l
1.4
1.6
0.61
36
148
(3011325) HIV 1+2 Ab [Presence] in Serum
19
107
0.91
0.10
1.0
1.0
—
—
—
0
0
(3001218) Citrate [Mass/time] in 24 hour Urine
5
23
1.11
0.10
1.8
1.3
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
10
44
1.16
0.10
1.1
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
1454
7500
0.99
0.09
1.5
1.4
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
6
28
1.10
0.09
1.0
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
49
239
1.05
0.09
1.2
1.3
—
—
—
0
0
(4212803)
27
129
1.07
0.08
1.1
1.0
—
—
—
0
0
(3007456) Orange IgE Ab [Units/volume] in Serum
7
32
1.12
0.08
1.0
1.0
u/ml
0.1
0.1
—
7
15
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
97
482
1.03
0.08
2.6
2.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
97
482
1.03
0.08
2.6
2.1
—
—
—
0
0
(3006598) pH of Arterial cord blood
29
158
0.94
0.08
1.0
1.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
273
1377
1.02
0.07
1.2
1.3
g/l
1.5
1.5
0.03
43
31
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
33
160
1.06
0.07
3.4
2.1
%
50.1
56.6
0.46
21
97
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
28
152
0.94
0.07
1.5
1.4
%
69.2
69.7
0.03
23
124
(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood
29
157
0.95
0.07
1.0
1.0
kpa
7.8
7.3
0.70
23
135
(3040151) Glucose [Moles/volume] in Capillary blood
406
2097
0.99
0.05
4.2
6.0
mmol/l
7.2
7.1
0.12
316
1729
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
69
361
0.98
0.03
1.4
1.2
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
29
154
0.96
0.03
1.0
1.0
mmol/l
-0.7
-1.7
—
5
38
(3034092) Cytoplasmic Ig cells/100 cells in Blood
34
169
1.03
0.02
9.3
7.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
33
174
0.97
0.02
1.1
1.1
g/l
17.0
17.7
0.14
26
156
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
45
234
0.98
0.00
1.2
1.2
mmol/l
20.5
20.5
0.01
36
193
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
40
208
0.98
0.00
8.8
6.7
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
27
139
0.99
0.00
1.1
1.1
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
37
189
1.00
0.00
1.5
1.2
mmol/l
1.6
1.5
0.03
26
113
(3000919) Neutrophils/100 leukocytes in Pleural fluid
87
446
1.00
0.00
1.3
1.4
%
24.3
22.1
0.31
78
406
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
58
295
1.01
0.00
2.5
2.3
mg/l
18.5
35.0
1.35
18
35
(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum
5
28
0.91
0.00
1.0
1.2
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
6
31
0.99
0.00
1.0
1.1
—
—
—
0
0
(3035963) Corticotropin [Moles/volume] in Plasma
0
5
0.00
0.00
0.0
1.0
—
12.5
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_MEDICAL_OBSER_EVALU_SUSPECTED_DISEA_CONDI – Medical observation and evaluation for suspected diseases and conditions
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).